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Abstract 
Objectives: Physical activity guidelines for older adults target high-intensity activities 
(i.e. increasing exercise), with less attention on low-intensity activities (i.e. 
reducing/interrupting sedentary behaviours) to improve health. Mobile health (mHealth) 
holds promise for engaging patients in self-management of chronic diseases. The purpose 
of this research was to prescribe physical activity of various intensities (i.e. sedentary 
through exercise) in primary care paired with mHealth for self-management.  
Methods: Sixty older adults (55-75yr) were randomly assigned to four groups: one 
control, and three receiving mHealth kits plus prescription for a specific intensity of 
physical activity (exercise, sedentary or both). Clinical measures (anthropometrics, blood 
pressure, aerobic fitness, glucose, lipid profile) were conducted in a primary care office. 
During the 12-week intervention, participants remotely submitted measures for physical 
activity, blood pressure, body weight, and blood glucose. Six-months post-intervention, 
aerobic fitness was measured and interviews were conducted.  
Results: Clinical and remotely submitted measures improved (p<0.05). Groups with a 
prescription including exercise demonstrated greater changes in home-monitored blood 
glucose than sedentary prescription alone (p<0.05). Following the intervention, gains 
made in aerobic fitness were maintained to six-months (p<0.05). Emergent themes from 
interviews included: mHealth for patient education and for creating social communities 
around health behaviours, as well as participant views of physical activity as medicine.  
Conclusions: To our knowledge, this is the first report of sedentary behaviour 
prescription in primary care. Findings support the ongoing practice of measuring 
lifestyle-related risk factors (e.g. body weight status, blood pressure, cardiorespiratory 
fitness) in the primary care setting for chronic disease management and prevention. 
Novel results demonstrate clinical benefits of prescribing changes to sedentary 
behaviours among older men and women. Additionally, results support the physiological 
and behavioural benefits of pairing physical activity prescription with mHealth for self-
monitoring among at-risk older adults.  
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Chapter 1  
1 Introduction 
Ontario’s older adults (>65 years) are living longer than previous generations, and 
generally with at least one chronic disease or condition.1 Older adults account for about 
15% of the population of Ontario, and about half of health care spending.1 The Seniors 
Strategy for Ontario1 highlights the essential role of primary care in the management of 
complex and interrelated health and social issues for older adults. 
 
Beyond provincial borders, global health systems are progressively being dominated by 
care for chronic conditions and non-communicable diseases. It is projected that in the 
coming decades deaths due to chronic conditions and non-communicable diseases like 
cardiovascular disease, cancer, and diabetes will account for nearly 60% of disease 
burden globally.2 Researchers and the medical community have long understood the 
importance of physical activity in promoting health.3,4 An active lifestyle is now 
understood to reduce both the morbidity and mortality of a wide range of chronic 
diseases, ranging from cancer (i.e. colon, breast) to cardiovascular disease, as well as 
protecting and promoting cognitive function.5-7 Insufficient levels of physical activity are 
responsible for six percent of global mortality, and are the fourth leading cause of death 
around the world.8 
 
1.1 Physical Activity 
It is well established in the literature that physical activity is an important component of 
health and wellness, including primary and secondary prevention of chronic and non-
communicable diseases. However, recent evidence indicates that 85% of Canadian adults 
are not meeting recommended guidelines for physical activity.9,10 Physically inactive 
lifestyles are the fourth leading cause of mortality, and contribute to over three million 
deaths globally each year.11 National Population Health Survey data from a representative 
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sample of Canadian older adults (aged >65 years) demonstrates an inverse relationship 
between physical activity participation and a number of chronic conditions,12 suggesting 
that older adults who are among the least physically active experience greater disease 
burden than their more active counterparts. Physical inactivity is a preventable risk factor 
for many lifestyle-related chronic conditions and diseases, and reducing physical 
inactivity represents a substantial opportunity for chronic disease prevention, health care 
cost savings, and improved quality of life. The World Health Organization’s guidelines 
for promoting physical activity among older adults reinforce the crucial role of regular 
engagement in physical activities for healthy and successful aging.13  
 
It is important to differentiate between physical activity, which is any bodily movement 
produced by skeletal muscles resulting in energy expenditure,14 and exercise, which is a 
subset of physical activity that is planned, structured, repetitive and for the purpose of 
improving or maintaining fitness.14 Despite their differences, and perhaps partially due to 
their overlapping constructs, the two terms are commonly, and incorrectly, used 
interchangeably in both the literature and clinical practice. For the purpose of this 
dissertation, physical activity will refer to the entire spectrum of daily activity behaviours. 
 
Figure 1.1 Continuum of Physical Activity Behaviours 
 
During waking hours, physical activities exist along a continuum which can be 
categorized by intensity and defined through metabolic equivalents (METs): ranging 
from low-intensity sedentary behaviours, such as sitting (i.e. <1.5 METs), through light 
physical activities, such as the incidental activities of daily living (i.e. 1.5-3.0 METs), to 
higher-intensity moderate- to vigorous-intensity physical activities (MVPA), such as 
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purposeful exercise (i.e. >3.0 METs) (Figure 1.1). Public health guidelines recommend 
150 minutes of MVPA weekly, in bouts of a minimum of 10 minutes, in order to 
maintain good health.15 Meeting physical activity guidelines for MVPA can promote 
healthy body weight status and cardiometabolic markers such as blood pressure, 
triglycerides, low- and high-density lipoprotein cholesterol.16 
 
Due to the established health benefits of MVPA, these higher-intensity activities are 
typically targeted in physical activity interventions. However, Canadian adults spend 
three quarters of waking hours each day engaged in sedentary behaviours, while just three 
percent engaged in MVPA17 thus the proportion of time spent in sedentary behaviours 
dwarfs that spent in MVPA. While the health importance of MVPA is well established, 
recent evidence suggests that sedentary behaviour (e.g. activity done while sitting)18 also 
plays an important role in the development of chronic disease. Not surprisingly, recent 
studies have estimated that sedentary behaviour may reduce the life expectancy of 
Western nations by one to two years.19,20  
 
1.1.1 Sedentary Behaviour 
Prolonged bouts of sedentary behaviours increase risk for lifestyle-related disease 
through adverse changes in cardiometabolic biomarkers (e.g. increased triglycerides, 
decreased high-density lipoprotein cholesterol), bone health (e.g. reduced bone mineral 
density), vascular health (e.g. peripheral vascular function, glucose tolerance), body 
weight status (e.g. obesity) and psychosocial health (e.g. quality of life, mental health, 
self-esteem).21-24 Importantly, these adverse outcomes are not offset by participation in 
MVPA,21-26 which is critical given that it is possible to accumulate high amounts of both 
sedentary behaviours and MVPA during a single day.21,24,27-29 Therefore, how we 
accumulate our physical activity throughout the day matters: interrupting sedentary time 
into smaller bouts is associated with better metabolic health.27-31  
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Shifting behaviours from sedentary to light-intensity may reduce cardiometabolic risk,28,29 
which has important implications for lifestyle interventions as this may be a more 
achievable behaviour to target than MVPA in part due to the substantial portion of daily 
living that Canadian adults spend in sedentary pursuits. It has been suggested that any 
brief and frequent muscular contraction throughout the day could be used to offset the 
molecular changes initiating metabolic disease caused by prolonged sedentary 
behaviours.21,32 Healy et al report that taking frequent (>600 breaks weekly), short (<5 
minutes) breaks in sedentary time is associated with reduced markers of cardiometabolic 
risks, including waist circumference, body mass index, 2-hour plasma glucose and 
lipids.29 Dunstan et al have shown that simply standing up from a seated position every 
20 minutes during the day can result in a reduction in markers of cardiometabolic risks in 
healthy adults.28  
 
Moreover, Katzmarzyk33 and van der Ploeg et al34 have reported decreased risk of all-
cause mortality among individuals who spend more time standing than sitting. 
Specifically, van der Ploeg at al34 used Australian survey data to demonstrate that time 
spent standing has a beneficial effect on all-cause mortality, and that this is independent 
of sitting time, physical activity level and disease status. Similarly, Katzmarzyk33 used 
Canadian survey data to demonstrate a strong relationship between standing time and 
cumulative survival, indicating that among physically inactive adults greater time spent 
standing is associated with lower risk of mortality. Interestingly, this relationship was 
most apparent among the least active individuals, suggesting a dose-response relationship 
whereby individuals who spend the most amount of time sitting can have the greatest 
effect on mortality risk by standing more. Katzmarzyk equates this finding with the 
similar effect of exercise (MVPA) interventions, whereby improving the 
cardiorespiratory fitness among least fit individuals (e.g. improving from ‘poor’ to ‘fair’ 
rating) has the greatest effect on health status change.33  
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However, to-date the relationship between time spent in sedentary behaviours and 
cardiometabolic health is observational, such that a cause and effect relationship remains 
to be established.35 Can we intervene to reduce sedentary time, and will this lead to 
improved health outcomes? Additionally, literature suggests that reducing sedentary time 
in addition to increasing MVPA may enhance the physiological benefits of modifying 
either behaviour independently.35 Yet there is a lack of evidence describing the clinical 
outcomes (i.e. effect on cardiometabolic markers) of intervening on both sedentary and 
exercise behaviours simultaneously.  
 
1.1.2 Prescribing Physical Activity in Clinic 
A written prescription holds symbolic meaning for patients, indicating that their health 
practitioner believes in the value of the behaviour for managing or promoting health.36 A 
health behaviour message (such as physical activity prescription) delivered by a 
healthcare provider may be an important stimulus for individual change.37 The Step Test 
and Exercise Prescription (STEP™) tool was designed to facilitate efficient, evidence-
based physical fitness assessment and tailored exercise prescription in the primary care 
setting.38 Research employing STEP™ has demonstrated beneficial effects on aerobic 
fitness, exercise compliance, exercise self-efficacy, and cardiometabolic risk profile.39 
Orrow et al40 identified STEP™ as a particularly effective tool for intervening on 
physical activity and fitness through primary care. Moreover, their systematic review and 
meta analysis of exercise (i.e. MVPA) prescription in primary care demonstrated that the 
practice improves both physical activity levels and cardiovascular health.40 However, 
85% of Canadian adults are not engaging in sufficient MVPA.17 This suggests that 
established approaches to exercise prescription may need to evolve to best meet the needs 
of patients and improve physical activity behaviours. 
 
Sedentary behaviour and MVPA are distinct physical activity behaviours with distinct 
health outcomes.21-26 While the evidence base demonstrating efficacy of exercise 
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prescription is well established, literature reporting the clinical effect of prescribing 
changes to sedentary behaviours has yet to be established. Moreover, patients are less 
likely to receive sedentary behaviour counselling from their healthcare provider.41 
Therefore, activity prescription targeting the low-intensity end of the physical activity 
continuum (namely, sedentary behaviours) is an emerging area of research.  
 
1.2 mHealth 
Mobile health (mHealth) is characterized by the use of mobile technologies in health care 
delivery. For example, the use of blood pressure monitors, glucometers, physical activity 
trackers (e.g. pedometers, accelerometers) and mobile communication devices (e.g. 
smartphones). mHealth technologies can promote patient engagement,42 which may be in 
part due to meaningful use and feedback for users. mHealth is a rapidly growing focus for 
chronic disease management and prevention,43 which is supported by the pervasive reach 
of these technologies across socioeconomic status and geographic region.44 mHealth 
facilitates access to individuals where they live, which could be leveraged to meet targets 
identified by the Senior Strategy for Ontario such as support for community and home 
care services.1 Ontario’s older adults, and their caregivers, seek information and services 
that facilitate opportunities to age-in-place and maintain independence.1 It is crucial that 
user-centered programs and services be developed and implemented to facilitate the 
adoption of healthy living behaviours now to promote healthy, independent aging. 
 
Commonly, mHealth interventions are designed to increase health behaviours or improve 
disease management.45 Typically these interventions are conducted with individuals 
already experiencing symptoms of disease, such as diabetes, hypertension, and metabolic 
syndrome. It has been suggested that mHealth helps engage individuals in on-going self-
management of prescribed physical activity behaviours for both disease management and 
prevention, in part through increased access to and perceived control over health services 
and knowledge.31,43,46-52 One of the key factors lending the potential of mHealth for 
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physical activity promotion is its ability to provide personalized and real-time feedback to 
users.45,53 This feature enables context-specific support for behaviour adoption, thereby 
enhancing learning and improving behavioural outcomes.53 While there is a substantial 
mismatch between the pace of technological advancement and scientific inquiry,45,53 the 
evidence for mHealth continues to emerge. However there is currently a gap in the 
literature describing the efficacy of mHealth for chronic disease prevention among 
apparently healthy older adults. 
 
1.3 Research Plan 
The literature for mHealth, exercise prescription, and physical activity behaviours 
demonstrates opportunities for advancement. Specifically, there is a lack of evidence 
reporting physical activity prescription of varying intensities (i.e. sedentary behaviour 
through MVPA) in the primary care setting as well as mHealth interventions among 
apparently healthy older adults. Previous research from our laboratory has implemented 
mHealth technologies paired with exercise prescription among adults with, or at risk for, 
metabolic syndrome in a rural setting.50,51,54-56 Building on this experience we aimed to 
conduct a physical activity prescription (both sedentary and MVPA) and mHealth 
intervention among apparently healthy, community-dwelling older men and women. 
Prior to this research there was a lack of evidence describing sedentary behaviour 
interventions through primary care as well as mHealth for prevention among apparently 
healthy older adults. We hypothesized that it would be feasible to conduct sedentary 
behaviour prescription (alone, or in conjunction with exercise) through the primary care 
setting, and that a group of healthy older adults would be willing to use mHealth to self-
monitor for chronic disease prevention.  
 
The overall aim of the present research was to address the previously identified gaps in 
mHealth and physical activity among a sample of older adults. This research was 
conducted in 2012. The intervention involved a convenience sample of 60 older adults 
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(55-75 years) who volunteered to participate. The total sample size was limited, 
pragmatically, due to the cost and availability of providing the mHealth technology kit to 
participants (described in chapter three). Data were collected in three phases: clinical 
testing, ongoing self-monitoring using mHealth, and post-intervention follow-up; and are 
presented through three papers. Results from the intervention are presented in chapters 
two through four: chapter two (Prescribing Physical Activity Through Primary Care) 
reports the clinical results; chapter three (mHealth and Self-Management) reports 
mHealth results; and chapter four (Longitudinal Follow-Up) reports post-intervention 
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Chapter 2 
2 Prescribing Physical Activity Through Primary Care 
 
A version of this chapter has previously been published: 
Knight E, Stuckey MI, Petrella RJ. Prescribing physical activity through primary care: 




Background: Physical activity guidelines recommend engaging in moderate- and 
vigorous-intensity physical activity to elicit health benefits. Similarly, these higher 
intensity ranges for activity are typically targeted in healthy living interventions (i.e. 
exercise prescription). Comparatively less attention has been focused on changing lower 
intensity physical activity (i.e. sedentary activity) behaviours. The purpose of this study 
was to explore the effects of prescribing changes to physical activity of various intensities 
(i.e. sedentary through exercise) through the primary care setting. 
Methods: Sixty older adults (aged 55 to 75 years; mean age 63 ± 5 years) volunteered to 
participate, and were randomly assigned to four groups: three receiving an activity 
prescription intervention targeting a specific intensity of physical activity (exercise, 
sedentary, or both), and one control group. During the 12-week intervention period 
participants followed personalized activity programs at home. Basic clinical measures 
(anthropometrics, blood pressure, aerobic fitness) and blood panel for assessing 
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cardiometabolic risk (glucose, lipid profile) were conducted at baseline (week 0) and 
follow-up (week 12) in a primary care office. 
Results: There were no differences between groups at baseline (p > 0.05). The 
intervention changed clinical (F(5,50) = 20.458, p <0.001, ηP2 = 0.672) and blood panel 
measures (F(5,50) = 4.576, p = 0.002, ηP2 = 0.314) of cardiometabolic health. Post hoc 
analyses indicted no differences between groups (p > 0.05). 
Conclusion: Physical activity prescription of various intensities through the primary care 
setting improved cardiometabolic health status. To our knowledge, this is the first report 
of sedentary behaviour prescription (alone, or combined with exercise) in primary care. 
The findings support the ongoing practice of fitness assessment and physical activity 
prescription for chronic disease management and prevention.  
 
Keywords: exercise prescription; sedentary prescription; primary care; chronic disease 
management; chronic disease prevention; Exercise Is Medicine 
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2.2 Introduction 
North America is in the midst of a demographic shift toward an increasingly aged 
population. It is estimated that within 25 years, approximately one quarter of the 
population will be classified as older adults.1 Moreover, life expectancies in developed 
counties are increasing by two years every decade.2 Accompanying increased age is the 
increased prevalence of multiple chronic conditions.3 Chronic disease is more prevalent 
with advanced age; therefore, the demographic shift toward advanced age is of concern 
for the availability and sustainability of health care resources.3,4 In the years to come, it is 
projected that deaths due to chronic conditions and non-communicable diseases like 
cardiovascular disease, cancer, and diabetes will contribute to 70% of all deaths, which 
will account for nearly 60% of the disease burden globally.5 Novel interventions aimed at 
disease prevention are needed among the aging population.  
 
It is well established in the literature that physical activity is an important component of 
health and wellness,6 including primary and secondary prevention of chronic and non-
communicable diseases. Recent evidence indicates that 85% of Canadian adults and 97% 
of American adults are not meeting recommended guidelines for physical activity.7,8 
Physically inactive lifestyles are the fourth leading cause of mortality, and contribute to 
>3 million deaths globally each year.9 Physical inactivity is a preventable risk factor for 
many lifestyle-related chronic conditions and diseases,10 and reducing physical inactivity 
represents a substantial opportunity for chronic disease prevention, health care cost 
savings, and improved quality of life.  
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Exercise Is Medicine® initiatives highlight the importance of prescribing activity through 
the primary care setting to manage health.11 A recent systematic review concluded that 
physical activity prescription in primary care significantly increases self-reported 
physical activity levels at 12 months, and has a positive, albeit non-significant, effect on 
cardiorespiratory fitness.12 The College of Family Physicians of Canada endorses the 
Step Test and Exercise Prescription (STEP™) tool as part of accredited continuing health 
education strategies for improving physical activity education among family physicians. 
Tools like STEP™ facilitate the measurement of aerobic fitness and prescription of 
physical activity by primary care physicians and allied health professionals in an office-
based setting.  
 
In addition to measuring exercise capacity and prescribing physical activity, mobile 
health technologies (mHealth) have demonstrated the potential for engaging individuals 
in ongoing self-management of activity behaviours and disease management.13-16 
Moreover, among a sample of individuals with metabolic syndrome, it was suggested that 
mHealth tools improved awareness of lifestyle factors for overall health, which may 
affect clinical markers and risk factors for cardiovascular disease.16,17 Therefore, mHealth 
holds the potential for promoting health and preventing disease by addressing many of 
the costly and disabling factors that lead to chronic and non-communicable diseases, 
including access to care and knowledge about disease risk.18  
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2.2.1 Physical Activity Intensity 
Physical activity can occur across a spectrum of intensities, from lower intensity 
sedentary behaviours (such as reading and watching television) to higher intensity 
exercise behaviours (such as vigorous walking and playing sports). Currently, the best 
evidence suggests that adults and older adults should be accumulating 150 minutes of 
moderate- to high-intensity physical activity on a weekly basis, and that this activity 
should occur at a minimum of 10 minutes in any single bout.19,20 These higher intensity 
ranges for physical activity are typically targeted in healthy living interventions, as well 
as incorporated in established tools for exercise prescription through primary care 
settings. Comparatively little attention has been focused to date on changing lower 
intensity physical activity (i.e. sedentary) behaviours. Additionally, it has been suggested 
that individuals may compensate for engaging in a prescribed bout of exercise by 
reducing incidental (i.e. low-intensity) activities in other parts of their daily routine.21 
That is, after participating in exercise, the individual may become less active for the 
remainder of the day—effectively increasing time spent engaged in sedentary pursuits.  
 
There is a growing evidence base demonstrating that time spent being sedentary is a 
health risk, and a potentially important health behaviour to target through lifestyle 
interventions as the consequences of sedentary time are independent of the protective 
effects of higher intensity physical activity.22-28 Moreover, previous reports highlight the 
importance of interrupting prolonged periods of sedentary time to reduce cardiometabolic 
disease risk.29 It has been suggested that promoting reductions in sedentary time may be a 
more achievable behaviour to change through counselling in the primary care setting 
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given that, compared with exercise behaviours, it requires smaller lifestyle changes to 
accomplish and may be more feasible to integrate into clinical practice than traditional 
exercise prescription.17 However, recent research has suggested that few attempts have 
been made to translate this evidence into clinical practice.17  
 
2.2.2 Objective 
The purpose of this study was to explore the effect of prescribing various intensities of 
physical activity, in conjunction with an mHealth intervention for ongoing self-
management, to elicit clinical changes for cardiometabolic risk. To the best of our 
knowledge, this intervention is the first study targeting both increases in exercise with 
reductions in sedentary behaviour in a single group of adult participants, thereby 
providing comprehensive counselling for the entire spectrum of physical activity 
intensities individuals typically engage in on a daily basis. Additionally, this study is the 





Previously, we conducted a pilot study using similar protocols (exercise prescription in 
conjunction with mHealth tools among a sample of older adults) over an eight-week 
period.16,17 Building on this experience, for the present study we were able to support 60 
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participants over a 12-week intervention period to explore the effect of prescribing 
various intensities of physical activity through primary care. The mHealth intervention is 
reported elsewhere.18 This study was conducted between April and December 2012 in 
Ontario, Canada.  
 
2.3.2 Participants 
Sixty community-dwelling men and women aged 55 to 75 years volunteered to 
participate in the intervention. Study flyers were posted in the community, and 
individuals were recruited through a primary care practice where they were approached 
by care practitioners during regularly scheduled clinic visits. We also queried the clinic 
database for potentially eligible patients. Exclusion criteria from previous STEP-based 
research interventions were followed, which included resting blood pressure ≥ 180/110 
mm Hg; type 1 diabetes; history of myocardial infarction, angioplasty, coronary artery 
bypass, or cerebrovascular ischemia; symptomatic congestive heart failure; atrial flutter; 
unstable angina; implanted pacemaker; second- or third-degree heart block; unstable 
pulmonary disease; unstable metabolic disease; use of medications known to affect heart 
rate (e.g. beta-blockers); started or changed dose of lipid lowering agent(s) within the 
previous three months; and any orthopedic condition restricting the ability to engage in 
physical activity. After screening for eligibility, participants were allocated to four groups 
based on a randomization schedule created using an online randomization tool 
(www.random.org/lists/). All subjects provided informed written consent as approved by 
Western University Health Sciences Research Ethics Board (Protocol No. 18700). 




This study involved four groups: three receiving an activity prescription intervention 
targeting a distinct intensity of physical activity along the activity spectrum, and one 
control group. Participants were not blinded to group allocation. 
2.3.3.1 Control Group 
The control (CT) group subjects (n = 15) completed clinic testing only, and did not 
receive additional intervention or restriction on their normal activity behaviours. 
2.3.3.2 Exercise Group 
The exercise (EX) group (n = 15) received a physical activity prescription targeting 
increases in high-intensity activity (i.e. exercise). The exercise prescription included 
training intensity (65% to 85% maximum heart rate) tailored to baseline aerobic fitness 
using the STEP™ tool,30 in conjunction with counselling based on public health 
guidelines for physical activity from the Canadian Society for Exercise Physiology19,20 
and guided by the Fogg Behavior Model.31 Personalized home-based daily exercise 
programs were devised with each participant and a Canadian Society for Exercise 
Physiology Certified Exercise Physiologist® (CSEP-CEP) working toward public health 
guidelines for physical activity of ≥ 150 minutes of aerobic exercise weekly (in a 
minimum of 10-minutes bouts) at the individual target training intensity, and resistance 
training on ≥ two days of the week.  
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2.3.3.3 Sedentary Behaviour Group 
The sedentary behaviour (SB) group (n = 14) received a physical activity prescription 
targeting decreases in low-intensity activities (i.e. sedentary behaviour). The sedentary 
prescription began with education about the importance of interrupting prolonged 
intervals (i.e. bouts > 20 minutes29) of sedentary time, and counselling based on the goal 
of interrupting prolonged bouts was incorporated in a process guided by the Fogg 
Behavior Model.31,32 In the absence of clinical guidelines for sedentary behaviour 
prescription, personal activity programs were devised with each participant and a CSEP-
CEP® to identify three to five behaviours in the daily routine, during waking hours, in 
which the participant was likely to be inactive for > 20 minutes. Personalized strategies 
were devised to interrupt this time. Table 2.1 lists the strategies that participants 
identified during the counselling session with the CSEP-CEP® for interrupting their 
sedentary time. The goal was to devise personal strategies to interrupt prolonged bouts of 
sedentary behaviour that the participant could engage in each day for the 12-week 
intervention period. Four categories or themes were identified from the participant-
generated strategies, and the strategies are presented in Table 2.1 grouped by theme.  
 
Table 2.1 Strategies for Modifying Sedentary Behaviour 
Interrupting	  prolonged	  sedentary	  time	  by	  adding	  movement	  on	  natural	  breaks:	  	  
§ When	  I’m	  watching	  TV	  at	  night,	  I	  will	  do	  exercise	  at	  the	  end	  of	  each	  hour	  (lunges,	  push-­‐
ups,	  side	  leans)	  
§ When	  I	  watch	  TV	  at	  night,	  I	  will	  do	  stair	  stepping	  on	  the	  commercial	  breaks	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§ When	  playing	  Scrabble	  on	  the	  computer,	  I	  will	  do	  counter	  push-­‐ups	  after	  each	  word	  
§ When	  I	  read	  the	  paper	  on	  the	  weekend,	  I	  will	  stand	  up	  between	  sections	  
§ I	  will	  stand	  up	  between	  songs	  when	  playing	  the	  piano	  for	  the	  next	  12	  weeks	  
§ I	  will	  do	  one	  cleaning	  chore	  (like	  vacuuming	  or	  dusting)	  at	  the	  end	  of	  a	  TV	  show	  I	  watch	  
on	  the	  PVR	  [personal	  video	  recorder]	  
§ I	  will	  walk	  up	  and	  down	  the	  stairs	  on	  commercial	  breaks	  when	  watching	  TV	  
§ I	  will	  do	  a	  lap	  on	  the	  stairs	  after	  I	  check	  my	  email	  for	  the	  day	  
§ When	  I	  am	  watching	  the	  evening	  news	  on	  TV,	  I	  will	  stand	  up	  during	  commercial	  breaks	  
every	  night	  for	  the	  next	  12	  weeks	  
§ On	  commercial	  breaks	  during	  TV	  I	  will	  take	  a	  moment	  to	  correct	  my	  posture,	  go	  get	  
water	  in	  the	  kitchen,	  or	  do	  deep	  breathing	  exercises	  
§ Between	  chapters	  while	  reading	  books,	  I	  will	  stand	  up	  and	  do	  15-­‐20	  heel	  raises	  
§ Do	  one	  lap	  of	  the	  stairs	  after	  each	  book	  chapter	  I	  read	  
§ Stand	  up	  &	  do	  one	  lap	  of	  the	  stairs	  during	  each	  commercial	  break	  while	  I	  watch	  TV	  at	  
night	  
§ When	  I’m	  watching	  TV,	  I	  will	  stand	  up	  on	  commercial	  breaks,	  and	  walk	  up	  &	  down	  two	  
flights	  of	  stairs	  
§ When	  I’m	  reading	  a	  book,	  I	  will	  do	  15-­‐20	  counter	  push-­‐ups	  between	  each	  chapter	  
§ When	  I’m	  watching	  TV,	  I	  will	  stand	  up	  on	  commercial	  breaks,	  and	  actually	  do	  the	  
exercises	  from	  my	  physiotherapist	  
Augmenting	  typically	  sedentary	  time	  with	  active	  options:	  	  
§ While	  ironing,	  I	  will	  do	  heel	  lifts	  (instead	  of	  standing	  still)	  
§ While	  brewing	  coffee,	  I	  will	  do	  push-­‐ups	  on	  the	  counter	  edge	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§ When	  I	  go	  for	  groceries,	  I	  will	  walk	  to	  the	  grocery	  store,	  or	  park	  in	  the	  furthest	  spot	  from	  
the	  door	  if	  I	  have	  to	  drive	  (like	  in	  bad	  weather	  or	  when	  buying	  heavy	  things)	  
§ When	  doing	  errands,	  I	  will	  look	  for	  the	  farthest	  parking	  spot	  from	  the	  door	  I	  can	  find	  (to	  
get	  in	  a	  few	  extra	  steps)	  
§ When	  at	  a	  mall	  and	  using	  the	  escalator,	  I	  will	  walk	  up	  it	  (instead	  of	  riding	  it)	  
§ Set	  the	  table	  outside	  the	  RV	  so	  that	  we	  eat	  meals	  out	  there	  instead	  (and	  have	  to	  carry	  
the	  stuff	  outside)	  
§ Do	  counter	  push-­‐ups	  while	  I	  wait	  for	  the	  oven	  to	  heat	  up,	  water	  to	  boil,	  or	  toast	  to	  pop	  
§ Use	  the	  stairs	  instead	  of	  an	  elevator	  (at	  work,	  in	  the	  mall,	  etc).	  When	  I	  can’t	  use	  the	  
stairs,	  I	  will	  walk	  up	  the	  escalator	  
Adding	  in	  extra	  bouts	  of	  low-­‐intensity	  activity:	  
§ I	  will	  use	  the	  “long	  route”	  when	  I	  walk	  my	  dog	  
§ I	  will	  use	  the	  far	  bathroom	  (instead	  of	  the	  one	  in	  my	  room)	  every	  time	  I	  use	  the	  
bathroom	  for	  the	  next	  12	  weeks	  
§ I	  will	  walk	  a	  long	  route	  to	  the	  mailbox	  every	  day	  when	  I	  check	  the	  mail	  for	  the	  next	  12	  
weeks	  
§ I	  will	  ride	  my	  bike	  (instead	  of	  driving)	  to	  the	  bank	  every	  time	  I	  go	  to	  the	  bank	  for	  the	  
next	  12	  weeks	  
§ Walk	  to	  the	  trailer	  park	  &	  back	  each	  morning	  after	  I	  finish	  my	  morning	  coffee	  
§ Take	  a	  long	  route	  to	  the	  mailbox	  to	  check	  the	  mail	  (like	  one	  lap	  around	  my	  apartment	  
building)	  
§ I	  will	  walk	  the	  driveway	  between	  glasses	  of	  wine	  at	  night	  
§ Three	  times	  each	  day	  (in	  the	  morning,	  when	  I	  get	  home	  from	  work,	  and	  at	  night	  before	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bed)	  I	  will	  do	  one-­‐two	  minutes	  of	  stair	  stepping	  
§ At	  lunch	  time	  at	  work,	  I	  will	  walk	  to	  a	  quiet	  room	  after	  I	  finish	  eating	  my	  lunch,	  to	  do	  5-­‐
10	  push-­‐ups	  on	  a	  counter	  or	  wall,	  and	  then	  walk	  back	  
§ On	  weekends	  (both	  Saturday	  &	  Sunday)	  I	  will	  go	  for	  a	  20	  minute	  walk	  around	  my	  
neighbourhood	  
§ Make	  more	  frequent	  trips	  down	  to	  the	  beach	  &	  back	  (instead	  of	  carrying	  everything	  
with	  me	  in	  one	  trip)	  
§ Play	  fetch	  with	  the	  dog	  outside	  (or	  be	  in	  the	  garden)	  for	  one	  hour	  each	  night	  after	  
dinner	  
Setting	  timers	  to	  deliberately	  interrupt	  sedentary	  time:	  
§ Set	  the	  timer	  on	  my	  microwave	  for	  22:22	  when	  watching	  TV	  or	  on	  the	  computer	  so	  that	  
I	  have	  to	  get	  up	  every	  22:22	  to	  shut	  it	  off	  and	  reset	  it	  
§ When	  I	  read,	  I	  will	  set	  a	  timer	  for	  20	  minutes	  so	  that	  I	  have	  to	  stand	  up	  and	  reset	  the	  
timer	  
§ Set	  the	  timer	  on	  my	  microwave	  for	  30	  minutes	  when	  I	  am	  doing	  any	  of	  the	  following	  
four	  activities:	  reading,	  knitting,	  watching	  TV,	  doing	  puzzles	  
§ When	  working	  on	  my	  computer	  at	  night,	  I	  will	  set	  my	  microwave	  timer	  for	  20	  minutes;	  
and	  every	  time	  it	  goes	  off,	  I	  will	  walk	  back	  to	  the	  kitchen	  to	  re-­‐set	  it,	  and	  then	  do	  10	  
step-­‐ups	  on	  the	  stairs	  before	  sitting	  back	  down	  at	  the	  computer	  
§ When	  I’m	  working	  on	  puzzles,	  I	  will	  keep	  an	  eye	  on	  my	  watch	  and	  every	  20	  minutes	  I	  will	  
stand	  up	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2.3.3.4 Comprehensive Counselling Group 
The comprehensive counselling (CC) group (n = 16) received a physical activity 
prescription targeting both increases in high-intensity (i.e. exercise) and decreases in low-
intensity (i.e. sedentary behaviour) activities following the processes described above. 
 
2.3.4 Measures 
All groups completed baseline (week 0) and follow-up (week 12) clinic visits in a 
primary care setting. Primary measurements included basic clinical measures that could 
be conducted by health professionals or by self-management (anthropometrics, blood 
pressure, aerobic fitness), and secondary measurements included a blood panel available 
to primary care physicians for assessing cardiometabolic disease risk associated with 
overweight and obesity.  
 
2.3.4.1 Primary Outcomes 
2.3.4.1.1 Anthropometrics 
Height (recorded to the nearest 0.5 cm) and weight (recorded to the nearest 0.1 kg) were 
measured with the subjects wearing light clothing but with their footwear removed, from 
which body mass index (BMI) was calculated. Waist circumference (WC) (recorded to 
the nearest 0.5 cm) was measured midway between the twelfth rib and the superior 
portion of the iliac crest on the right-hand side of the participant following normal 
exhalation. 
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2.3.4.1.2 Blood Pressure  
Clinic blood pressure (BP) was measured with the subjects in a seated position, with the 
back supported and the left arm resting at heart height using an automatic cuff (BpTru®, 
Coquitlam, Canada). Three measures were conducted with a two-minute rest between 
measures. The average of the last two measures were recorded (to the nearest 1 mm Hg).  
2.3.4.1.3 Cardiorespiratory Fitness 
The self-paced submaximal stepping protocol from the STEP™ tool was used to predict 
functional aerobic fitness (maximum oxygen consumption, VO2max). The protocol is 
described elsewhere.30 Briefly, the stepping protocol involves a validated self-paced test 
from which post-exercise heart rate and the time to complete the test are entered, along 
with age, sex, and BMI, into a prediction equation for VO2max.  
2.3.4.2 Secondary Outcomes 
A fasting (eight hours) blood draw was conducted in accordance with the usual standard 
of care, and specimens were analyzed by a local laboratory (Gamma-Dynacare, London, 
Canada). The blood panel included analysis of fasting glucose, total cholesterol, 
triglycerides, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein 
(LDL) cholesterol.  
 
2.3.5 Statistical Analysis 
Analyses were conducted on an IBM SPSS® Statistics Version 20 (Chicago, IL). 
Significance for all statistical tests was set at p < 0.05. An independent samples t-test was 
conducted to test the differences between the study sample and a representative sample of 
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Canadian adults from the Canadian Health Measures Survey.33 Repeated measures 
multivariate analysis of variance (MANOVA) were conducted for the primary analysis of 
basic clinic measures (anthropometrics, blood pressure, cardiorespiratory fitness) as well 
as for secondary analysis of the blood panel (fasting plasma glucose, cholesterol, 
triglycerides) to test for changes over time (baseline to follow-up clinic visits), with 
univariate analyses to determine which variables changed over time. Interactions were 
examined to test for the effect of group assignment over time. Data are presented as mean 




2.4.1 Subject Characteristics 
Figure 2.1 presents the flow of participants. The characteristics of the randomized 
participants are shown in Table 2.2. Participants’ mean age was 63 (± 5) years. Although 
no specific disease state or diagnosis was required for inclusion, participants were, on 
average, overweight or obese. The sample was no different from an age-matched 
representative sample of Canadian adults33 for anthropometrics (BMI, WC) or predicted 
aerobic capacity (VO2max) (p = 0.911). Of the 60 participants, 59 (98.3%) completed the 
study. The reason for the loss to follow-up of the one subject could not be established, 
and data were excluded listwise from analysis. No adverse events were reported during 
the intervention.  
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Figure 2.1 Flow of Participants 
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Table 2.2 Demographic and Clinical Characteristics of Participants at Baseline 
(n=60) 
Characteristic	   CT	  
(n	  =	  15)	  
SB	  
(n	  =	  14)	  
EX	  
(n	  =	  15)	  
CC	  
(n	  =	  16)	  
p	  value	  
Demographics	   	   	   	   	   	  
Age	  (y)	   62	  (5)	   63	  (4)	   63	  (5)	   62	  (4)	   0.979	  
Sex	  distribution	  (%	  female)	   73	   64	   46	   56	   0.507	  
Primary	  Measures	   	   	   	   	   	  
BMI	  (kg/m2)	   31.9	  (5)	   33.8	  (4)	   30.4	  (5)	   29.6	  (6)	   0.152	  
WC	  (cm)	   105.7	  (12)	   114.1	  (18)	   107.8	  (16)	   98.9	  (15)	   0.060	  
Systolic	  BP	  (mm	  Hg)	   129.5	  (13)	   130.3	  (17)	   131.1	  (18)	   121.4	  (15)	   0.295	  
Diastolic	  BP	  (mm	  Hg)	   81.1	  (7)	   80.1	  (7)	   79.8	  (10)	   76.8	  (10)	   0.549	  
VO2max	  (mL/kg/min)	   28.9	  (8)	   25.2	  (5)	   30.9	  (9)	   29.5	  (5)	   0.172	  
Secondary	  Measures	   	   	   	   	   	  
Fasting	  glucose	  (mmol/L)	   4.5	  (0.4)	   5.4	  (1.5)	   5.1	  (1.3)	   5.4	  (1.5)	   0.141	  
Total	  cholesterol	  (mmol/L)	   4.9	  (0.9)	   4.7	  (1.6)	   5.1	  (1.0)	   5.5	  (1.4)	   0.284	  
Triglycerides	  (mmol/L)	   1.3	  (0.6)	   1.6	  (0.6)	   1.7	  (0.9)	   1.3	  (0.6)	   0.249	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LDL	  cholesterol	  (mmol/L)	   2.7	  (0.8)	   2.4	  (1.2)	   2.9	  (0.8)	   3.3	  (1.1)	   0.084	  
HDL	  cholesterol	  (mmol/L)	   1.6	  (0.5)	   1.6	  (0.6)	   1.4	  (0.5)	   1.6	  (0.5)	   0.763	  
Abbreviations: CT, Control group; SB, Sedentary group; EX, Exercise group; CC, 
Comprehensive group; BMI, body mass index; WC, waist circumference; BP, blood 
pressure; VO2max, aerobic capacity; LDL, low-density lipoprotein; HDL, high-density 
lipoprotein; p < 0.05 denotes significant difference between groups. 
 
2.4.2 Primary Outcomes 
Primary analysis of this intervention included health status variables that can be measured 
by health practitioners or by individuals themselves for ongoing self-management. The 
difference in clinic measures was significant from baseline to follow-up (F(5,50) = 20.458, 
p <0.01, ηP2 = 0.672). Post-hoc analysis using Tukey’s honestly significant difference 
correction indicated that this difference was not significant between groups (p > 0.05). 
Table 2.3 presents the univariate analyses, which determined statistically significant 
changes from baseline to follow-up for all groups in BMI, WC, diastolic BP, and 
VO2max, with no change in systolic BP. Figure 2.2 shows the mean changes for primary 
measures over time, and Table 2.4 presents pairwise comparisons for primary outcomes 
from pre- to post-intervention. 
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Figure 2.2 Changes in Primary Markers 
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Table 2.3 Primary Analysis 


































Note: Data presented as mean (± standard deviation) with 95% confidence interval [lower 
bound–upper bound]. 
Abbreviations:  BMI, body mass index; WC, waist circumference; BP, blood pressure; 
VO2max, aerobic capacity; p<0.05 denotes significant difference. 
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Table 2.4 Pairwise Comparisons of Primary Outcomes 
	  
Mean	  difference	  (standard	  error)	  
95%	  confidence	  interval	  	  
[lower–upper	  bound]	   p	  value	  
BMI	  (kg/m2)	  
CT	   –0.3	  (0.2)	   [–0.8	  –	  0.2]	   0.190	  
SB	   –0.7	  (0.2)	   [–1.1	  –	  –0.2]	   0.009	  
EX	   –0.4	  (0.2)	   [–	  0.9	  –	  0.1]	   0.079	  
CC	   –0.4	  (0.2)	   [–0.9	  –	  0.0]	   0.063	  
WC	  (cm)	  
CT	   –3.5	  (1.4)	   [–6.4	  –	  –0.6]	   0.018	  
SB	   –4.8	  (1.5)	   [–7.8	  –	  –1.8]	   0.002	  
EX	   –5.7	  (1.4)	   [–8.6	  –	  –2.8]	   <0.01	  
CC	   –3.0	  (1.4)	   [–5.8	  –	  –0.2]	   0.036	  
Systolic	  BP	  (mm	  Hg)	  
CT	   –6.8	  (3.7)	   [–14.2	  –	  0.6]	   0.072	  
SB	   –5.4	  (3.78)	   [–13.0	  –	  2.3]	   0.168	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EX	   –4.2	  (3.7)	   [–11.6	  –	  3.2]	   0.262	  
CC	   5.9	  (3.6)	   [–1.3	  –	  13.1]	   0.107	  
Diastolic	  BP	  (mm	  Hg)	  
CT	   –6.4	  (1.9)	   [–10.1	  –	  –2.7]	   0.001	  
SB	   –3.7	  (1.9)	   [–7.6	  –	  0.1]	   0.058	  
EX	   –3.7	  (1.9)	   [–7.4	  –	  0.1]	   0.053	  
CC	   –0.3	  (1.8)	   [–3.9	  –	  3.3]	   0.863	  
VO2max	  (mL/kg/min)	  
CT	   1.9	  (0.7)	   [0.5	  –	  3.4]	   0.010	  
SB	   2.9	  (0.8)	   [1.4	  –	  4.4]	   <0.01	  
EX	   2.1	  (0.7)	   [0.6	  –	  3.5]	   0.006	  
CC	   3.4	  (0.7)	   [1.9	  –	  4.7]	   <0.01	  
Abbreviations: CT, Control group; SB, Sedentary group; EX, Exercise group; CC, 
Comprehensive group; BMI, body mass index; WC, waist circumference; BP, blood 
pressure; VO2max, aerobic capacity; p<0.05 denotes significant difference. 
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2.4.3 Secondary Outcomes 
Secondary analysis of this intervention included markers for cardiometabolic risk 
available to a physician for assessing the health status of overweight and obese patients. 
The difference in blood panel measures was significant from baseline to follow-up (F(5,50) 
= 4.576, p = 0.002, ηP2 = 0.314). Post-hoc analysis using Tukey’s honestly significant 
difference correction indicated that this difference was not significant between groups (p 
> 0.05). Table 2.5 presents the univariate analyses, which determined statistically 
significant changes from baseline to follow-up for all groups in fasting glucose, total 
cholesterol, and triglycerides, but no difference in HDL cholesterol or LDL cholesterol. 
Figure 2.3 shows the mean changes for secondary measures over time, and Table 2.6 
presents pairwise comparisons for secondary outcomes from pre- to post-intervention. 
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Figure 2.3 Changes in Secondary Outcomes 
Note: * denotes statistically significant change (p < 0.05). 
 
 
Table 2.5 Secondary Analysis 










































Note: Data presented as mean (± standard deviation) with 95% confidence interval [lower 
bound–upper bound]. 
Abbreviations:  LDL, low-density lipoprotein; HDL high-density lipoprotein; P < 0.05 
denotes significant difference. 
 
Table 2.6 Pairwise Comparisons of Secondary Outcomes 
	  
Mean	  difference	  (standard	  error)	  
95%	  confidence	  interval	  	  
[lower–upper	  bound]	   p	  value	  
Fasting	  glucose	  (mmol/L)	  
CT	   0.6	  (0.2)	   [0.3	  –	  1.0]	   0.001	  
SB	   0.3	  (0.2)	   [–0.1	  –	  0.7]	   0.086	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EX	   –0.1	  (0.2)	   [–0.5	  –	  0.3]	   0.544	  
CC	   0.2	  (0.2)	   [–0.1	  –	  0.5]	   0.259	  
Total	  cholesterol	  (mmol/L)	  
CT	   –0.2	  (0.1)	   [–0.4	  –	  0.1]	   0.280	  
SB	   –0.2	  (0.1)	   [–0.5	  –	  0.0]	   0.094	  
EX	   –0.1	  (0.1)	   [–0.4	  –	  0.2]	   0.499	  
CC	   –0.1	  (0.1)	   [–0.4	  –	  0.2]	   0.461	  
Triglycerides	  (mmol/L)	  
CT	   –0.1	  (0.1)	   [–0.3	  –	  0.1]	   0.145	  
SB	   –0.4	  (0.1)	   [–0.6	  –	  0.2]	   0.001	  
EX	   –0.1	  (0.1)	   [–0.4	  –	  0.1]	   0.198	  
CC	   0.0	  (0.1)	   [–0.2–	  0.2]	   0.926	  
LDL	  cholesterol	  (mmol/L)	  
CT	   –0.1	  (0.1)	  	   [–0.4	  –	  0.1]	   0.398	  
SB	   –0.1	  (0.1)	   [–0.3	  –	  0.2]	   0.680	  
EX	   0.0	  (0.1)	   [–0.2	  –	  0.3]	   0.805	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CC	   –0.1	  (0.1)	  	   [–0.2	  –	  0.3]	   0.506	  
	  HDL	  cholesterol	  (mmol/L)	  
CT	   0.0	  (0.1)	   [–0.1	  –	  0.1]	   0.831	  
SB	   0.0	  (0.1)	   [–0.1	  –	  0.9]	   0.879	  
EX	   –0.6	  (0.1)	   [–0.2	  –	  0.1]	   0.203	  
CC	   0.0	  (0.0)	   [–0.1	  –	  0.7]	   0.710	  
Abbreviations: CT, Control group; SB, Sedentary group; EX, Exercise group; CC, 
Comprehensive group; LDL, low-density lipoprotein; HDL, high-density lipoprotein; 
p<0.05 denotes significant difference. 
 
2.5 Discussion 
Among the leading risks for mortality globally are high BP, blood glucose, body weight 
status, and physical inactivity.34 Best practice and evidence support intervening on 
cardiometabolic risk factors (e.g. elevated blood pressure, blood glucose, and body 
weight) prior to the development of chronic conditions such as hypertension, type 2 
diabetes, and metabolic syndrome. Moreover, early identification and treatment with 
lifestyle modification has been advised for the prevention of hypertension, type 2 
diabetes, and cardiovascular disease.35 In the present study, cardiometabolic risk factors 
were improved pre- to post-intervention.   




On average, BMI decreased by 0.5 kg/m2 (p < 0.05) but remained in the obese category 
post-intervention. The WC provides an assessment of body fat distribution, and better 
identifies patients at higher cardiometabolic risk than does BMI alone.36 Additionally, 
WC is an important indicator of diabetes, coronary heart disease, and mortality rate, 
independent of other clinical measures such as BP and blood markers like glucose and 
lipoproteins.36 In the present study, the mean reduction in WC across all groups was 4.3 
cm (p < 0.05). It has been suggested that a reduction in WC of ≥ 3.0 cm reduces 
cardiometabolic risk.36-38 Moreover, similar to other physical activity intervention studies, 
previous STEP™ interventions ranging from eight to 24 weeks have elicited reductions 
in WC of between 2.6 and 3.9 cm.16,17,34,35 Therefore, reductions in WC in the present 
study may be considered clinically meaningful.  
 
2.5.2 Blood Pressure 
Thompson et al39 suggest that following a 12-week physical activity intervention, 
normotensive patients could be expected to reduce systolic BP by 2.6 mm Hg and 
diastolic BP by 1.8 mm Hg. Mean changes in BP were similar across all groups, and 
although not statistically significant, changes in BP among the present study sample can 
be considered clinically relevant (2.5 mm Hg reduction in systolic BP, and 3.4 mm Hg 
reduction in diastolic BP).   
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2.5.3 Cardiorespiratory Fitness 
In a recent systematic review of exercise prescription interventions delivered in the 
primary care setting, Orrow et al12 concluded that there was a small effect on aerobic 
fitness, which was primarily driven by a single intervention that employed the STEP™ 
tool. The authors attributed this effect to the unique study characteristic of STEP™ 
interventions, which is inclusion of a target training intensity (heart rate) in the 
prescription process. Previously published STEP™ interventions, ranging between 8 
weeks and 12 months in duration, have increased aerobic fitness 7% to 18%.30 In the 
current study, we observed an increase from baseline to follow-up of 8.5%, or 2.7 
mL/kg/min (p < 0.05), which is within the range reported by previous STEP™ 
interventions.  
 
2.5.4 Blood Panel 
Clinical practice guidelines for managing and treating obesity recommend assessment of 
blood markers for cardiometabolic risk, including fasting plasma glucose, total 
cholesterol, triglycerides, and LDL and HDL cholesterol.40 Figure 2.3 shows the mean 
changes over time for blood panel measures from the present study. The sample was on 
average obese at baseline; however, blood panel markers were within normal or desired 
ranges. Despite this, most clinical markers showed statistically significant changes 
following the intervention. Although fasting glucose increased significantly from baseline 
to follow-up, this change may not be considered clinically meaningful given that the post-
intervention average remained within normal values (3.6–6.0 mmol/L). Total cholesterol 
and triglycerides decreased following the intervention, and values both pre- and post-
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intervention were within the clinically desired range (< 5.2 mmol/L and < 2.3 mmol/L, 
respectively). Similarly, the mean LDL and HDL cholesterol following the intervention 
remained unchanged and within clinically desired thresholds (< 3.0 mmol/L and > 1.0 
mmol/L, respectively).  
 
2.5.5 Physical Activity Behaviour 
When prescribing lifestyle changes to manage metabolic risk, it is important to 
acknowledge the physiological difference between excess sitting and insufficient 
exercise.41 It has been suggested that prolonged intervals of sedentary time should be 
avoided to prevent increases in metabolic risk, and that any type of brief and frequent 
muscular contraction throughout the day could be used to offset the molecular changes of 
prolonged sedentary time and the signals causing metabolic disease.23,41 Independent of 
exercise, maintaining high levels of light-intensity activity throughout the day may be 
important for reducing metabolic risk factors. The health risks of prolonged intervals of 
sedentary activity in human and animal models are documented in the literature. A recent 
systematic review of sedentary time in humans concluded that prolonged intervals of 
sedentary behaviour may lead to undesirable changes in fasting glucose, HDL and LDL 
cholesterol, as well as triglycerides, which may help to explain associations that have 
been drawn between sedentary behaviour and chronic disease morbidity and mortality.41 
In the present study, there was no difference in changes in fasting glucose and HDL and 
LDL cholesterol between groups (p > 0.05). This indicates that all groups, including the 
group receiving clinic testing only (CT group) changed similarly across the 12-week 
intervention period. Results are limited to the small sample in the present study, and may 
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be further influenced by the baseline characteristics of study participants being generally 
within clinically desirable (or normal) thresholds for these measures.  
 
2.5.6 Prescribed Health Behaviours 
There is evidence to suggest that a health behaviour message delivered by a health 
practitioner, such as through primary care, can be an important stimulus for individual 
change and adoption of prescribed health behaviours.42 Moreover, it has been suggested 
that a written exercise prescription holds symbolic meaning for patients by indicating that 
their health practitioner believes in the value of exercise for managing and promoting 
health.43 Health practitioners are in a unique position to educate patients about the 
importance of reducing, or interrupting, daily sedentary time. Previously it has been 
shown that more patients receive exercise counselling from their physician than 
counselling focused on reducing sedentary behaviour.26 Moreover, recent research has 
demonstrated that counselling for sedentary behaviours through the primary care setting 
is more likely to occur for obese patients, whereas exercise counselling is more likely to 
be conducted for younger patients, non-smokers, and patients with dyslipidemia.26 
Results from the current study support the feasibility of counselling to change sedentary 
behaviours through the primary care setting.  
 
In addition to the physiological difference between exercise and sedentary activity, health 
practitioners may also consider the complex nature of human behaviour when attempting 
to manage cardiometabolic risk with lifestyle modification. For example, individuals may 
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decrease non-exercise activities following a bout of exercise driven by the psychological 
belief that they are entitled to a rest following the energy expended during exercise.21 
This may lead to an overall reduction in physical activity during non-exercise time, as 
there is evidence to suggest that individuals compensate by decreasing their routine 
activities during non-exercise activity.21 This supports the importance of prescribing 
activity across the range of intensities that an individual can participate in (i.e. sedentary 
through exercise, or comprehensive counselling).  
 
However, counselling on the broad spectrum of activity intensities through the primary 
care setting may be too intensive to realize health benefits for patients. To the best of our 
knowledge, this is the first study to report a comprehensive counselling approach in a 
single group of adults. In pediatric psychology research, Epstein et al44 have explored a 
group-based comprehensive counselling approach reinforcing activity choices, decreased 
sedentary activities, or both. They found that the children in the sedentary group showed 
the best improvements in body weight status as compared with the exercise and 
combined groups. In their study, the authors suggested that multiple changes required in 
the combined group may have made it more difficult for participants to make individual 
exercise and sedentary changes, which may have diluted the intervention effect.44 
Similarly, in the present study individuals in the CC group, on average, showed the 
smallest improvements from pre- to post-intervention as compared to other intervention 
groups (Table 2.7). This may suggest that counselling for the range of activity intensities 
(e.g. sedentary, exercise) during a single clinic visit may be too intensive to realize 
changes. Future studies are warranted exploring the effect of staged comprehensive 
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counselling, where, instead of during a single visit, counselling for changes in activity 
behaviours progressively incorporates exercise and sedentary activities.  
 
Table 2.7 Mean Changes by Group 




VO2max	  (mL/kg/min)	   	   	  
CT	   28.93	  (7.1)	   30.87	  (6.5)	  
SB	   25.22	  (5.3)	   28.16	  (5.4)	  
EX	   30.85	  (8.6)	   32.93	  (8.1)	  
CC	   25.51	  (5.1)	   32.85	  (5.9)	  
Body	  mass	  index	  (kg/m2)	   	   	  
CT	   31.92	  (5.2)	   31.61	  (4.8)	  
SB	   33.81	  (4.3)	   33.16	  (4.3)	  
EX	   30.36	  (5.4)	   29.95	  (5.0)	  
CC	   29.63	  (5.9)	   29.21	  (5.9)	  
Waist	  circumference	  (cm)	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CT	   105.67	  (12.0)	   102.13	  (12.1)	  
SB	   114.07	  (17.5)	   109.25	  (16.7)	  
EX	   107.83	  (15.6)	   102.13	  (15.7)	  
CC	   98.91	  (14.6)	   95.91	  (13.2)	  
Systolic	  BP	  (mm	  Hg)	   	   	  
CT	   129.47	  (13.9)	   122.67	  (13.9)	  
SB	   130.29	  (16.8)	   124.93	  (13.2)	  
EX	   131.13	  (18.1)	   126.93	  (17.3)	  
CC	   121.44	  (14.9)	   127.31	  (16.6)	  
Diastolic	  BP	  (mm	  Hg)	   	   	  
CT	   81.13	  (7.5)	   74.73	  (9.2)	  
SB	   80.07	  (7.1)	   76.36	  (10.2)	  
EX	   79.80	  (9.6)	   76.13	  (9.2)	  
CC	   76.75	  (10.4)	   76.44	  (9.5)	  
Fasting	  glucose	  (mmol/L)	   	   	  
CT	   4.48	  (0.4)	   5.05	  (0.3)	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SB	   5.38	  (1.5)	   5.69	  (1.6)	  
EX	   5.09	  (1.3)	   4.98	  (1.0)	  
CC	   5.44	  (1.5)	   5.63	  (1.1)	  
Total	  cholesterol	  (mmol/L)	   	   	  
CT	   4.85	  (0.9)	   4.71	  (1.0)	  
SB	   4.69	  (1.6)	   4.45	  (1.3)	  
EX	   5.09	  (1.0)	   5.00	  (0.9)	  
CC	   5.52	  (1.4)	   5.42	  (1.4)	  
Triglycerides	  (mmol/L)	   	   	  
CT	   1.33	  (0.6)	   1.25	  (0.6)	  
SB	   1.61	  (0.6)	   1.21	  (0.2)	  
EX	   1.68	  (0.9)	   1.53	  (0.6)	  
CC	   1.29	  (0.6)	   1.28	  (0.6)	  
HDL	  cholesterol	  (mmol/L)	   	   	  
CT	   1.59	  (0.4)	   1.58	  (0.4)	  
SB	   1.55	  (0.6)	   1.54	  (0.5)	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EX	   1.47	  (0.5)	   1.41	  (0.4)	  
CC	   1.61	  (0.5)	   1.59	  (0.5)	  
LDL	  cholesterol	  (mmol/L)	   	   	  
CT	   2.66	  (0.8)	   2.56	  (0.9)	  
SB	   2.40	  (1.2)	   2.35	  (1.0)	  
EX	   2.85	  (0.9)	   2.88	  (0.8)	  
CC	   3.32	  (1.1)	   3.25	  (1.1)	  
Abbreviations: CT, Control group; SB, Sedentary group; EX, Exercise group; CC, 
Comprehensive group; VO2max, functional aerobic capacity; BP, blood pressure; HDL, 
high-density lipoprotein; LDL, low-density lipoprotein. 
 
A health risk message delivered through the primary care setting can be a potent catalyst 
initiating physical activity–related health behaviour change.42 However, Pfeiffer et al43 
found no difference in self-reported activity level between written exercise prescription 
versus verbal exercise advice among a group of community-dwelling older adults, 
although their study was limited to recalled activity types and durations and did not 
assess physiological markers. Through the current study, we found statistically and 
clinically significant effects for clinical markers following a 12-week intervention period 
across both the control and treatment groups. These results further support the clinical 
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importance of measuring risk factors for lifestyle-related conditions through primary 
care. Although caution should be exercised in interpreting results from a single study, 
these findings could support the clinical utility of measuring and providing attention for 
managing cardiometabolic risk through the primary care setting as a potentially important 
treatment effect.  
 
2.5.7 Placebo Effect 
Findings from the present study demonstrate improvements from baseline to follow-up 
clinic visits across all groups. Participants were not blinded to group allocation and were 
aware of the purpose of the study from reading informed consent forms for participation. 
Often referred to as the placebo or Hawthorne effect, it has been widely accepted that an 
individual’s behaviour can be modified by the psychological awareness of being 
observed and included in an intervention, which is a nonspecific effect of participating in 
clinical research. It has been suggested that extra attention from researchers and 
clinicians through participation in an intervention applies to both treatment and control 
arms, and that psychological and social factors from participation may overestimate the 
treatment effect for both types of participant groups.45 Anecdotally, multiple participants 
in the CT group of the present study reported at follow-up (week 12) clinic testing that 
they had initiated dietary and activity changes to their lifestyles since the baseline clinic 
testing visit. The present study was not designed to record and control for this effect. 
Results from the present study support the clinical utility of measuring lifestyle-related 
disease risk factors through the primary care setting. 
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2.5.8 Strengths and Limitations 
Exclusion criteria restricted participation of individuals using medication that would alter 
heart rate (e.g. beta-blockers), as heart rate response to activity was essential to the 
measure of aerobic capacity used in the present study. However, individuals with high 
blood pressure, a common effect of high body weight status and unhealthy physical 
activity behaviours, were eligible to participate in the current study. Excluding 
individuals who were at high risk of cardiovascular complications would inhibit the 
ability to detect changes in health markers over a 12-week intervention period. 
 
The short intervention period (12 weeks) may have further inhibited our ability to detect 
changes among intervention groups that might have emerged over a longer time period. 
Results from the present study help to demonstrate the clinical value of tailoring activity 
behaviour counselling to various intensities (i.e. ranging from sedentary behaviour 
through exercise), as changing sedentary behaviours may have implications for 
cardiometabolic risk. Moreover, the results imply that enhancing an individual’s 
understanding of disease risk, such as measuring cardiometabolic risk through the 
primary care setting, may be an important stimulus for change. The results from the 
present study can be used to help inform the design of future investigations of prescribing 
various intensities of physical activity through the primary care setting.  
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Participants received personal activity programming tailored to baseline cardiorespiratory 
fitness. Individual differences in prescribed activities were not controlled for. Objective 
measures of physical activity (via pedometer) during the 12-week intervention period are 
reported elsewhere.18 The present analysis did not include a measure of physical activity 
level. This study explored the effect of prescribing activities of different intensities on 
clinical outcome measures that would typically be collected in the primary care setting.  
 
Previously there has been a gap in the literature reporting sedentary behaviour 
interventions that include cardiometabolic measures to assess change in clinical outcomes 
of cardiometabolic risk.46 The primary strength of this study stems from the fact that it is 
the first study to present clinical results pertaining to sedentary behaviour prescription, 
alone and in conjunction with exercise prescription, in the primary care setting. The 
results, although limited to the small sample size, could help to inform future 
interventions aimed at decreasing sedentary time as well as the development of practice 
guidelines for the counselling and prescription of sedentary behaviours by health 
practitioners. Moreover, findings from the present study may be used to draw inferences 
about expected treatment outcomes, and may be of value in the design of future 
investigations prescribing various intensities of physical activity through the primary care 
setting. Future exploratory analyses may be warranted to describe characteristics of 
individuals who responded to the present physical activity intervention; however, the 
current study was not powered for this analysis. An understanding of these characteristics 
may help clinicians identify individuals who are most likely to respond to intervention.  




The present study investigated the effect of prescribing various intensities of physical 
activity through the primary care setting on cardiometabolic risk factors. Changes in 
primary and secondary outcomes of cardiometabolic health status were statistically 
significant and clinically meaningful, with no difference between groups. Novel results 
demonstrate clinical benefits of prescribing changes to low-intensity physical activities 
(i.e. sedentary behaviours) for older men and women. Moreover, findings support the 
ongoing practice of measuring lifestyle-related disease risk factors (e.g. body weight 
status, blood pressure, cardiorespiratory fitness) in the primary care setting for chronic 
disease management and prevention.  
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Chapter 3 
3 mHealth and Self Management 
 
A version of this chapter has previously been published: 
Knight E, Stuckey MI, Petrella RJ. Health promotion through the primary care setting: 
Enhancing self-management with home health monitoring technologies and activity 




Background: It is well established in the literature that regular participation in physical 
activity is effective for chronic disease management and prevention. Remote monitoring 
technologies (i.e. mHealth) hold promise for engaging patients in self-management of 
many chronic diseases. The purpose of this study was to test the effectiveness of an 
mHealth study with tailored physical activity prescription targeting changes in various 
intensities of physical activity (e.g. exercise, sedentary behaviour, or both) for improving 
physiological and behavioural markers of lifestyle-related disease risk. 
Methods: Forty-five older adults (aged 55 to 75 years; mean age 63 ± 5 years) were 
randomly assigned to receive a personal activity program targeting changes to either daily 
exercise, sedentary behaviour, or both. All participants received an mHealth technology 
kit including smartphone, blood pressure monitor, glucometer, and pedometer. 
Participants engaged in physical activity programming at home during the 12-week 
intervention period and submitted physical activity (steps/day), blood pressure (mm Hg), 
   
63 
body weight (kg), and blood glucose (mmol/L) measures remotely using study-provided 
devices. 
Results: There were no differences between groups at baseline (p > 0.05). The 
intervention had a significant effect (F(10,488) = 2.947, p = 0.001, ηP2 = 0.057), with 
similar changes across all groups for physical activity, body weight, and blood pressure 
(p > 0.05). Changes in blood glucose were significantly different between groups, with 
groups prescribed high-intensity activity (i.e. exercise) demonstrating greater reductions 
in blood glucose than the group prescribed changes to sedentary behaviour alone (p < 
0.05). 
Conclusions: Findings demonstrate the utility of pairing mHealth technologies with 
activity prescription for prevention of lifestyle-related chronic diseases among an at-risk 
group of older men and women. Results support the novel approach of prescribing 
changes to sedentary behaviours (alone, and in conjunction with exercise) to reduce risk 
of developing lifestyle-related chronic conditions.  
 
Keywords: mobile health; exercise prescription; sedentary behaviour; primary care; 
chronic disease prevention; exercise is medicine. 
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3.2 Introduction 
It has been well established in the literature that regular participation in physical activities 
is effective for managing and preventing many chronic and non-communicable diseases. 
Despite this, developed countries continue to report that adults and older adults are not 
meeting public health guidelines for physical activity.1,2 Interventions aimed at improving 
physical activity behaviours typically target increases in high-intensity activities such as 
exercise. However, there is a growing body of evidence to suggest that time spent being 
sedentary is a distinct health risk and a potentially important behaviour to target through 
physical activity interventions.3-6 Predominantly inactive lifestyles present substantial 
consequences for public health around the globe.7  
 
In developed countries, individuals are living longer than previous generations, yet there 
is a disparity between longevity and healthy, independent living; increased life 
expectancies are not matched with fewer years of disability and ill health.8 Moreover, 
global health systems are progressively being dominated by care for chronic conditions 
and non-communicable diseases.9,10 As the number of patients continues to grow and the 
health care resources continue to strain, engaging patients in self-management may be an 
effective strategy for disease prevention and management. 
 
3.2.1 Physical Activity Prescription 
Evidence suggests that the delivery of a health risk message by a health professional can 
initiate and promote patient adoption of healthy lifestyle behaviours.11 A written exercise 
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prescription expresses symbolic meaning that a health professional values the role of 
exercise for managing and promoting health.12 The importance of prescribing activity 
through the primary care setting to manage cardiometabolic risk is further underscored by 
Exercise Is Medicine® initiatives. Moreover, physical activity prescription through the 
primary care setting has been shown to significantly increase physical activity levels as 
well as have a positive effect on cardiorespiratory fitness.13 Health professionals are in a 
unique position to educate patients about the importance of interrupting sedentary 
activities as well as the health benefits of exercising.14 However, it has previously been 
demonstrated that patients are more likely to receive exercise counselling than sedentary 
behaviour counselling from their physician.5 As we become increasingly aware of the 
health risks of prolonged sedentary behaviours,15-17 novel interventions are needed that 
target sedentary activities as well as exercise behaviours.  
 
3.2.2 Remote Monitoring 
The use of mobile communication devices in the health landscape, commonly referred to 
as mobile health (mHealth), enables remote monitoring of individuals. The use of mobile 
phones is pervasive around the world, and leveraging the utility and accessibility of 
mobile technologies holds much potential for health behaviour interventions. Currently 
there are an estimated 6.9 billion mobile phone subscribers globally, and 2.1 billion 
smartphone (i.e. broadband-enabled phone) subscriptions globally.18 Comparatively 
fewer individuals are using landlines and the Internet at home (1.2 billion and 696 
million, respectively),18 which are platforms that have previously been leveraged for 
delivering health behaviour interventions (i.e. electronic, or eHealth). In North America, 
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98% of Americans and 75% of Canadians are mobile phone subscribers.18 Therefore, the 
availability of mHealth for rich, complex, and frequent data sharing and self-monitoring 
supports its utility for the modification of various health behaviours,19 and the prevalence 
of mobile phones both in North America and around the world support the growing value 
of mHealth interventions in the global health landscape. Moreover, mHealth technologies 
involving smartphones are a rapidly expanding focus of preventive care for chronic 
disease management.20 
 
Remote monitoring technologies have been cited for improving health by improving 
access to information and services, providing care not otherwise deliverable and 
enhancing care delivery.21 Pilot work from our research group has demonstrated the 
efficacy of self-monitoring using remote technologies to manage body weight, blood 
pressure, and blood glucose among adults with metabolic syndrome, and it was suggested 
that the mHealth tools provided to study participants improved awareness of lifestyle 
factors for overall health to effect clinical markers and risk factors for cardiometabolic 
disease.22,23 Moreover, the remote monitoring in these studies has improved participants’ 
overall sense of well-being, and provided a sense of security to participants during an 
eight-week healthy living intervention.23 The mHealth evidence base predominantly 
focuses on diseased populations (e.g. individuals who are diabetic, hypertensive, or 
obese), and limited information is available describing the effect of mHealth on 
apparently healthy populations for the purpose of disease prevention. Leveraging the 
utility of mHealth, the purpose of this study was to prescribe changes to a range of 
physical activity intensities (i.e. exercise, sedentary, or both) using tailored activity 
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prescription to improve clinical and behavioural markers of lifestyle-related 





Previously, we have piloted similar protocols (exercise prescription in conjunction with 
remote self-management tools) over an eight-week period.22,23 Building on this 
experience, for the present study we were able to feasibly support 45 participants with the 
remote monitoring technologies over a 12-week intervention period. This study was 
conducted between April and December 2012.  
 
3.3.2 Participants 
A convenience sample of 45 community-dwelling men and women aged 55 to 75 years 
volunteered to participate in the intervention. Individuals were generally healthy, with no 
diagnosis (e.g. hypertensive, diabetic, obese) required for inclusion. Participants were 
recruited through study advertisements posted in the community as well as enrolment 
through a local primary care setting. Exclusion criteria were followed from similar 
interventions previously conducted by our group that facilitate safe participation in a 
physical activity intervention: resting blood pressure ≥ 180/110 mm Hg; type 1 diabetes; 
history of myocardial infarction, angioplasty, coronary artery bypass, or cerebrovascular 
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ischemia; symptomatic congestive heart failure; atrial flutter; unstable angina; implanted 
pacemaker; second- or third-degree heart block; unstable pulmonary disease; unstable 
metabolic disease; use of medications known to affect heart rate (e.g. beta-blockers); 
started or changed dose of lipid lowering agent(s) within the previous three months; and 
any orthopedic condition restricting the ability to engage in physical activity. After 
screening for eligibility, participants were divided into three groups based on a 
randomization schedule created using an online randomization tool 
(www.random.org/lists/). All subjects provided informed written consent as approved by 




Participants were randomized at recruitment into three intervention groups: (1) exercise 
(EX), in which participants received a physical activity prescription targeting increases in 
high-intensity activity (i.e. exercise); (2) sedentary behaviour (SB), in which participants 
received a physical activity prescription targeting reductions and interruptions in low-
intensity daily activity (i.e. sedentary behaviour); and (3) comprehensive (CC), in which 
participants received an activity prescription targeting both increases in high-intensity 
activity (i.e. exercise) and reductions in low-intensity activity (i.e. sedentary behaviour). 
Further details regarding the activity prescription process are reported elsewhere.14  
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3.3.3.2 Technology Kit  
A technology kit containing mHealth devices for home self-monitoring was loaned to 
participants in all three groups free of charge for the duration of the 12-week 
intervention. Participants were provided with a smartphone (BlackBerry™ Curve 8530), 
Bluetooth-enabled blood pressure monitor (A&D Medical, No. UA-767PBT), 
Glucometer (Lifescan One Touch Ultra 2™) with Polymap wireless adaptor (PWR-08-
03), and a pedometer (Omron No. HJ-150). Participants used their own weight scales for 
measuring body weight. All Bluetooth-compatible devices were paired with a unique 
study-provided smartphone. An application linking measures to a secure study database 
(Healthanyhwere™, Biosign Technologies Inc., Thornhill, Ontario, Canada) was installed 
on the smartphone to manage health measures. The smartphone transmitted data to the 
study database in real time, interfaced participants with research personnel, and allowed 
participants to monitor their personal health indicators.  
3.3.3.2.1 Data Transmission and Security 
When participants measured blood pressure and glucose, the reading was automatically 
sent to their smartphone via the Bluetooth connection. Measures for body weight and 
physical activity were manually entered by participants into their smartphone. The 
smartphone transmitted measures through a wireless network to the study database. Each 
submitted measure automatically updated the participant’s profile on the server in real-
time. The study database was hosted on Healthanywhere servers, which is a secure 
repository for the participant’s study-related health information. Data security protocols 
are available elsewhere.22 Data of 500 MB per month were enabled for 12 months on 
each smartphone, which included roaming to allow participants to travel within North 
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America. If participants traveled outside the data coverage area, measures were stored at 
the time of measurement and automatically updated to the server, via smartphone, upon 
return to the data coverage area.  
 
3.3.4 Measures 
Physical activity (steps) was measured daily. Body weight (kg) was measured once 
weekly using the participant’s own weight scale. Blood pressure (mm Hg) was measured 
in a seated position three times weekly (two weekdays and one weekend day) upon 
waking. Fasting blood glucose (mmol/L) was measured once weekly. Participants were 
instructed on proper measurement technique and device use at baseline. Additionally, 
they were provided with a hardcopy troubleshooting guide and contact information for 
study personnel for further questions regarding either device operation or measurement 
procedures.  
 
3.3.5 Statistical Analysis 
Analyses were conducted in IBM SPSS® Statistics Version 20 (IBM, Chicago, IL). 
Blood pressure and physical activity measures were each averaged to a single weekly 
reading for analysis. A minimum of two submitted measures were required to compute 
the weekly average value. Missing values varied from 0% to 11% of cases across the five 
variables (physical activity, body weight, systolic blood pressure, diastolic blood 
pressure, and blood glucose) spanning the 12-week intervention. Regression with 
variables of age, sex, and group assignment was used to test that missing values were 
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missing completely at random. Multiple imputation (five sets) was used to replace 
missing values for analysis, and the imputed data files were used for parametric analyses. 
Significance for all statistical tests was set at p < 0.05. Repeated measures of multivariate 
analysis of variance (MANOVA) were conducted to test the effect of the intervention on 
changes in remotely submitted measures over time. Univariate analyses were examined to 
test for effects of group assignment over time. Data are presented as mean (± standard 




3.4.1 Subject Characteristics 
Figure 3.1 presents the flow of participants. Forty-five volunteers (25 women and 20 
men) completed the 12-week intervention. The mean age of the sample was 63 (± 5) 
years. Sample characteristics are presented in Table 3.1. There were no differences 
between groups at baseline for demographic (age, sex) or physiological markers (blood 
pressure, fasting plasma glucose).14  
 
   
72 




   
73 
Table 3.1 Sample Characteristics (n=45) 
Characteristic	   SB	  
(n	  =	  14)	  
EX	  
(n	  =	  15)	  
CC	  
(n	  =	  16)	  
Demographics	   	   	   	  
Age	  (y)	   63	  (4)	   63	  (5)	   62	  (4)	  
Sex	  distribution	  (%	  female)	   64	   46	   56	  
Clinical	  Measures	   	   	   	  
BMI	  (kg/m2)	   33.8	  (4)	   30.4	  (5)	   29.6	  (6)	  
WC	  (cm)	   114.1	  (18)	   107.8	  (16)	   98.9	  (15)	  
Systolic	  BP	  (mm	  Hg)	   130.3	  (17)	   131.1	  (18)	   121.4	  (15)	  
Diastolic	  BP	  (mm	  Hg)	   80.1	  (7)	   79.8	  (10)	   76.8	  (10)	  
Fasting	  glucose	  (mmol/L)	   5.4	  (1.5)	   5.1	  (1.3)	   5.4	  (1.5)	  
Abbreviations: SB, Sedentary group; EX, Exercise group; CC, Comprehensive group; 
BMI, body mass index; WC, waist circumference; BP, blood pressure. 
 
3.4.2 Outcomes 
The mean change in remotely submitted home-monitored variables is presented in Table 
3.2. The multivariate analysis of variance revealed a significant effect of the intervention 
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during the 12-week home-monitoring period (F(10,488) = 2.947, p = 0.001, ηP2 = 0.057). 
Univariate comparisons using Greenhouse-Geisser correction indicated no difference in 
changes between groups for physical activity (F(2,247) = 1.615, p = 0.201, ηP2 = 0.013), 
body weight (F(2,247) = 2.147, p = 0.119, ηP2 = 0.017), or blood pressure (systolic, F(2,247) = 
1.260, p = 0.286, ηP2 = 0.010; diastolic, F(2,247) = 0.520, p = 0.595, ηP2 = 0.004). 
 
Table 3.2 Mean Change in Self-Monitored Measures Over Time 
	  
Mean	  difference	  (standard	  error)	  
95%	  confidence	  interval	  	  
[lower–upper	  bound]	   p	  value	  
Physical	  activity	  (steps/day)	  
SB	   460	  (375)	   [–278	  –	  1199]	   0.22	  
EX	   –76	  (364)	   [–792	  –	  640]	   0.84	  
CC	   –454	  (345)	   [–1134	  –	  225]	   0.19	  
Body	  weight	  (kg)	  
SB	   –0.8	  (1.3)	   [–3.3	  –	  1.7]	   0.52	  
EX	   2.8	  (1.2)	   [0.4	  –	  5.3]	   0.02	  
CC	   0.7	  (1.2)	   [–1.6	  –	  3.0]	   0.54	  
Systolic	  BP	  (mm	  Hg)	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SB	   –3	  (1)	   [–5	  –	  0]	   0.06	  
EX	   –6	  (1)	   [–8	  –	  –3]	   <0.01	  
CC	   –5	  (1)	   [–7	  –	  –2]	   <0.01	  
Diastolic	  BP	  (mm	  Hg)	  
SB	   –4	  (1)	   [–6	  –	  –3]	   <0.01	  
EX	   –4	  (1)	   [–5	  –	  –2]	   <0.01	  
CC	   –4	  (1)	   [–6	  –	  –3]	   <0.01	  
Blood	  glucose	  (mmol/L)	  
SB	   –0.1	  (0.1)	   [–0.4	  –	  0.2]	   0.51	  
EX	   –0.4	  (0.1)	   [–0.7	  –	  –0.2]	   <0.01	  
CC	   –0.8	  (0.1)	   [–1.0	  –	  –0.5]	   <0.01	  
Abbreviations: SB, Sedentary group; EX, Exercise group; CC, Comprehensive group; 
BP, blood pressure; p<0.05 denotes significance.  
 
Changes were significantly different between groups for fasting blood glucose (F(2,247) = 
5.978, p = 0.003, ηP2 = 0.046). Post-hoc analysis using Tukey’s honestly significant 
difference revealed no difference in change in blood glucose between the EX and CC 
groups (p > 0.05); however, there was a difference between the SB and CC groups (p < 
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0.05) as well as the SB and EX groups (p < 0.05). Mean remotely submitted weekly 
measures are listed in Table 3.3. Mean changes by group are presented in Figures 3.2 to 
3.5. 
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Figure 3.3 Change in Body Weight by Group 
Note: * denotes statistical difference (p < 0.05) between groups. 
 
 
Figure 3.4 Change in Blood Pressure by Group 
Note: * denotes statistical difference (p < 0.05) between groups. 
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Figure 3.5 Change in Blood Glucose by Group 
Note: * denotes statistical difference (P < 0.05) between groups. 
 
Table 3.3 Average Weekly Readings by Intervention Group 
Physical	  activity	  (steps/day)	  
	  
SB	   EX	   CC	  
Week	  1	   6343	  (3325)	   9258	  (5412)	   9194	  (3306)	  
Week	  2	   6759	  (3572)	   9458	  (4304)	   9688	  (3961)	  
Week	  3	   6865	  (4258)	   9913	  (5159)	   9214	  (4067)	  
Week	  4	   6536	  (3674)	   9913	  (5415)	   9198	  (3455)	  
Week	  5	   6719	  (3576)	   9960	  (5850)	   9802	  (3954)	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Week	  6	   7068	  (3776)	   9961	  (5487)	   9069	  (2979)	  
Week	  7	   7243	  (3506)	   9838	  (4210)	   9119	  (3524)	  
Week	  8	   6671	  (3278)	   9002	  (4691)	   9029	  (3364)	  
Week	  9	   6877	  (3808)	   9382	  (4651)	   8931	  (3110)	  
Week	  10	   8090	  (5452)	   9746	  (4903)	   9315	  (3830)	  
Week	  11	   6906	  (4366)	   9130	  (5285)	   9084	  (3573)	  
Week	  12	   6809	  (3624)	   9195	  (6094)	   8762	  (3578)	  
Body	  weight	  (kg)	  
	  
SB	   EX	   CC	  
Week	  1	   97.1	  (20.2)	   82.3	  (18.2)	   83.5	  (17.0)	  
Week	  2	   96.2	  (20.0)	   82.6	  (17.5)	   81.6	  (17.5)	  
Week	  3	   96.7	  (20.1)	   82.4	  (17.4)	   83.2	  (16.5)	  
Week	  4	   98.3	  (18.6)	   82.0	  (17.3)	   81.5	  (17.2)	  
Week	  5	   95.4	  (19.2)	   82.2	  (17.6)	   84.1	  (17.0)	  
Week	  6	   96.9	  (19.6)	   79.4	  (14.4)	   82.3	  (15.7)	  
Week	  7	   91.8	  (12.0)	   80.8	  (17.0)	   81.8	  (15.8)	  
Week	  8	   96.5	  (19.1)	   81.3	  (17.0)	   81.6	  (17.5)	  
Week	  9	   90.7	  (11.9)	   79.1	  (14.8)	   82.8	  (16.6)	  
Week	  10	   97.1	  (17.7)	   82.1	  (11.7)	   81.3	  (17.4)	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Week	  11	   95.0	  (19.4)	   81.4	  (10.6)	   80.3	  (16.4)	  
Week	  12	   96.4	  (18.6)	   85.4	  (13.1)	   84.3	  (15.4)	  
Systolic	  blood	  pressure	  (mm	  Hg)	  
	  
SB	   EX	   CC	  
Week	  1	   135	  (19)	   129	  (16)	   131	  (13)	  
Week	  2	   133	  (16)	   128	  (18)	   128	  (13)	  
Week	  3	   131	  (12)	   127	  (18)	   124	  (13)	  
Week	  4	   131	  (13)	   127	  (15)	   124	  (14)	  
Week	  5	   131	  (15)	   126	  (16)	   124	  (14)	  
Week	  6	   129	  (15)	   123	  (19)	   126	  (11)	  
Week	  7	   133	  (17)	   123	  (19)	   	  124	  (11)	  
Week	  8	   130	  (13)	   126	  (13)	   123	  (10)	  
Week	  9	   127	  (18)	   124	  (12)	   122	  (9)	  
Week	  10	   130	  (13)	   127	  (18)	   124	  (11)	  
Week	  11	   129	  (15)	   126	  (15)	   123	  (13)	  
Week	  12	   132	  (12)	   124	  (12)	   126	  (12)	  
Diastolic	  blood	  pressure	  (mm	  Hg)	  
	  
SB	   EX	   CC	  
Week	  1	   86	  (9)	   81	  (9)	   83	  (10)	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Week	  2	   83	  (8)	   78	  (10)	   80	  (9)	  
Week	  3	   82	  (7)	   78	  (8)	   78	  (9)	  
Week	  4	   83	  (7)	   78	  (6)	   79	  (11)	  
Week	  5	   82	  (7)	   78	  (9)	   78	  (10)	  
Week	  6	   81	  (9)	   76	  (8)	   80	  (10)	  
Week	  7	   83	  (8)	   77	  (9)	   78	  (8)	  
Week	  8	   82	  (7)	   77	  (8)	   79	  (8)	  
Week	  9	   80	  (7)	   77	  (7)	   78	  (6)	  
Week	  10	   84	  (6)	   78	  (8)	   80	  (8)	  
Week	  11	   82	  (8)	   77	  (10)	   78	  (9)	  
Week	  12	   81	  (8)	   77	  (8)	   78	  (9)	  
Fasting	  blood	  glucose	  (mmol/L)	  
	  
SB	   EX	   CC	  
Week	  1	   6.6	  (1.4)	   6.6	  (1.4)	   6.7	  (1.7)	  
Week	  2	   6.3	  (1.6)	   6.1	  (1.0)	   5.9	  (0.7)	  
Week	  3	   6.1	  (1.2)	   6.3	  (1.3)	   6.0	  (0.9)	  
Week	  4	   6.4	  (1.3)	   6.4	  (1.4)	   6.1	  (1.2)	  
Week	  5	   6.3	  (1.4)	   6.0	  (0.8)	   6.0	  (1.0)	  
Week	  6	   6.3	  (1.1)	   6.0	  (0.9)	   6.1	  (1.0)	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Week	  7	   6.2	  (0.9)	   6.1	  (0.8)	   6.3	  (1.3)	  
Week	  8	   6.2	  (1.3)	   5.9	  (0.8)	   5.9	  (1.1)	  
Week	  9	   6.2	  (1.0)	   6.0	  (0.9)	   6.2	  (1.3)	  
Week	  10	   6.4	  (1.4)	   6.2	  (1.4)	   5.8	  (0.8)	  
Week	  11	   6.2	  (1.1)	   6.1	  (1.1)	   5.6	  (0.9)	  
Week	  12	   6.5	  (1.2)	   6.2	  (1.1)	   5.9	  (1.0)	  
Note: Participants submitted weekly readings remotely using mHealth technology kit. 
This table lists the values of submitted readings by intervention group for the 12-week 
remote monitoring and physical activity intervention. 
Abbreviations: SB, Sedentary group; EX, Exercise group; CC, Comprehensive group. 
 
3.5 Discussion 
This study examined the effect of pairing mHealth tools for home self-monitoring with 
personalized activity prescriptions targeting various intensities of physical activity 
(sedentary, exercise, or both) to remotely manage health and cardiometabolic risk. 
Changes in home-monitored measures were significant during the 12-week intervention. 
Across all three groups, changes in physical activity, body weight, and blood pressure 
were similar, whereas change in blood glucose was significantly better for the groups that 
were prescribed exercise. Results are novel in that they demonstrate that prescribing 
physical activity in conjunction with mHealth devices for ongoing self-monitoring holds 
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promise for changing lifestyle-related disease risk among at-risk, but otherwise healthy, 
older men and women.  
 
3.5.1 Physical Activity 
At week one, all groups had received, and it is assumed initiated, their physical activity 
prescriptions for this intervention. Although significance was not achieved (p < 0.05), the 
EX and CC groups tended to engage in more steps per day than the SB group during the 
course of the intervention (Table 3.3), indicating that the groups engaging in prescriptions 
that included higher intensity physical activity (EX and CC groups) accumulated more 
steps per day. In the present study the SB group incrementally improved daily physical 
activity by increasing the average steps per day from week one to 12 (p > 0.05). The 
gradual increase in daily activity of the group prescribed changes to low-intensity 
physical activity only (SB group) suggests that prescribing changes to sedentary 
behaviours may lead to progressive increases in daily activity behaviours. Moreover, an 
early sedentary behaviour intervention among community-dwelling older adults by 
Gardiner et al24 determined that individuals educated about sedentary time increased their 
light- and moderate- to vigorous-intensity physical activity as measured by 
accelerometer. Although the present study used a less sophisticated device for measuring 
daily physical activity, the results are promising and further demonstrate the benefit of 
pedometers as an mHealth tool for increasing physical activity levels.  
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3.5.2 Body Weight 
Body weight status is an indication of lifestyle-related disease risk. This study was 
designed to educate patients about their body weight (e.g. ongoing self-measurement). 
Changes in home-monitored body weight varied across groups from reduction in the SB 
group (p > 0.05), to increases in the EX (p < 0.05) and CC groups (p > 0.05) (Table 3.2). 
A meta-analysis of walking interventions without a dietary component concluded that 
healthy adults may reduce body weight by 0.05 kg per week of intervention.25 In the 
current study, across all groups the average home-monitored body weight increased 
marginally from week one to 12 (p > 0.05), which may demonstrate that the physical 
activity prescription and mHealth tools were on average not effective at managing body 
weight status as compared with a pedometer-based walking intervention alone. However, 
although not statistically significant, results are promising in that they may support the 
novel approach of prescribing changes to sedentary behaviours for weight management. 
 
3.5.3 Blood Pressure 
Although the majority of mHealth interventions that involve remote self-monitoring of 
blood pressure include a population of hypertensive patients, a systematic review of 
pedometer-based physical activity interventions including individuals who were 
predominantly normotensive at baseline concluded that clinic systolic and diastolic blood 
pressure could decrease by 3.8 mm Hg and 0.3 mm Hg, respectively.26 It has also been 
suggested that normotensive individuals engaged in 12-week physical activity 
intervention, without an mHealth component, may reduce systolic blood pressure by 2.6 
mm Hg and diastolic blood pressure by 1.8 mm Hg.27 In the present study, mean home-
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monitored systolic blood pressure was reduced by 4.2 mm Hg and diastolic blood 
pressure by 4.0 mm Hg (Table 3.3), with reductions in systolic and diastolic blood 
pressure significant across all groups (Table 3.2). Moreover, these improvements are 
greater than previously identified for physical activity and mHealth interventions among 
normotensive patients. Therefore, changes in systolic and diastolic blood pressure also 
may be considered clinically meaningful across all groups in the present study. 
 
3.5.4 Blood Glucose 
At baseline, participants in our sample had, on average, fasting blood glucose within 
clinically desirable thresholds (3.6–6.0 mmol/L). It has been suggested that glucose-
normal individuals could be expected to reduce their fasting plasma glucose by 0.03 
mmol/L following a physical activity intervention.26 In our sample, reduction in home-
monitored blood glucose ranged between 0.1 mmol/L for the SB group (p > 0.05) and 0.8 
mmol/L for the CC group (p < 0.05) (Table 3.2). Mean changes in blood glucose were 
significant for the groups prescribed higher intensity activity (EX and CC groups). 
Results support the effectiveness of prescribing exercise to manage blood glucose as well 




mHealth technologies can be used to assist both health professionals and patients in 
evidence-based self-management care and prevention.20 Previous research has shown that 
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remote monitoring technologies enable participants to share in the responsibility for their 
own health, while also providing a new understanding of their overall health and physical 
fitness.22 In the present study, the smartphone portal allowed participants to submit 
measures to the study database, communicate with study personnel, and self-monitor 
indicators of health status. Results of the participant’s acceptance of and experience using 
the mHealth technology kit employed in the present study for remote self-management 
are presented elsewhere.28  
 
It has been suggested that the value of telemedicine for the management of chronic 
conditions is weak and even contradictory.29 Free et al30 found that mHealth interventions 
aiming to change physical activity behaviours (with and without dietary intervention) led 
to a small clinical benefit or none at all. However, studies included in their systematic 
review were predominantly based on text messaging protocols, which is a single 
functionality of mobile phones. Furthermore, there is an abundance of literature reporting 
the use of this limited functionality of mobile phones, and a Cochrane Systematic Review 
concluded that there is little evidence to support the effectiveness of mobile messaging 
services (i.e. texting, or short message service) for chronic disease prevention.31 In 
contrast, smartphones allow for the diverse use of mobile technologies, including pairing 
with peripheral devices to allow for measurement of multiple health parameters (e.g. 
body weight, blood glucose, blood pressure). Recently, it was suggested that the effect of 
mHealth interventions is hampered by the limited use of messaging functionalities only, 
which has restricted the ability to draw evidence-based conclusions about the 
effectiveness of smartphones on various health behaviours.32  
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Failure to implement telemedicine interventions commonly descends from the 
technology’s acceptance, financing, application policy, and legislation for use in 
practice.33 Using widely available devices may help to improve implementation of 
findings from remote health monitoring studies into clinical practice. However, the cost 
of supplying these devices to individuals is immense. For example, in the present study 
the cost of the devices included in the technology kit as well as the data plan enabled on 
each smartphone for the 12-week intervention was approximately $34 000 (25 
technology kits at $1000 each, data plan subscription for the 25 smartphones at $9000). 
Future researchers may wish to examine the feasibility of using devices that subjects 
already have access to, thereby reducing costs and limiting duplication in technology. 
Moreover, leveraging devices individuals are familiar with using may enhance adherence 
to the self-management and remote monitoring protocols, potentially further enhancing 
the clinical effect. 
 
3.5.6 Strengths and Limitations 
mHealth has the potential to promote health and prevent disease by addressing many of 
the costly and disabling factors that lead to chronic and non-communicable diseases, 
including access to care and knowledge about disease risk. To date, mHealth 
interventions have primarily involved individuals already experiencing symptoms of 
disease (e.g. diabetes, hypertension, obesity). The present study explored the effect of 
mHealth technologies in conjunction with prescribed changes to various intensities of 
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physical activity (i.e. sedentary, exercise, or both) to improve risk factors for preventing 
various lifestyle-related chronic conditions. Among the present sample of typical, 
community-dwelling older men and women, the mHealth intervention involving physical 
activity prescription effectively improved behavioural and physiological risk factors for 
chronic disease among all three groups.  
 
Recruitment advertisements indicated the use of smartphones as well as other self-
management technologies in the present study. Therefore, it is likely that individuals with 
low motivation for the use of mHealth technologies would not have volunteered. 
Participants’ baseline comfort with using mHealth devices could potentially impact 
behavioural and clinical outcomes. The present investigation was not designed to control 
for familiarity with technology. However, all participants were trained individually at 
baseline to ensure that they knew how to use the devices. Additionally, individuals 
interested in learning to use the technologies may have been more inclined to change 
their behaviours compared with those who did not volunteer to participate in the 
intervention. All participants who enrolled in the study completed the 12-week 
intervention, which suggests that the present sample may be more highly motivated than 
the average clinic population. 
 
The findings reported here are limited to the small sample of highly motivated 
individuals who volunteered for the present study. The primary factor limiting sample 
size was the cost of providing the mHealth component of the intervention. Future 
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research is warranted to further demonstrate the efficacy of mobile technologies for 
chronic disease prevention among a sample of healthy individuals. Additionally, 
exploratory analyses may be warranted to determine characteristics of individuals most 
likely to respond to an mHealth behavioural intervention.  
 
3.5.7 Conclusion 
This study explored the effect of pairing mHealth with a physical activity prescription for 
changing physiological and behavioural markers of lifestyle-related chronic disease risk. 
The results support the effectiveness of home health monitoring for self-management of 
health risk. Moreover, findings suggest that prescribing changes to sedentary behaviours 
may be an effective strategy for chronic disease prevention. To the best of our 
knowledge, this is the first mHealth study involving prescribed changes to sedentary 
behaviours (alone, and in conjunction with exercise) to manage and prevent lifestyle-
related chronic conditions among a cohort of healthy, older adults. More research is 
needed to further explore the effect of mHealth for preventing the development of 
lifestyle-related chronic disease among at-risk individuals. 
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Chapter 4 
4 Longitudinal Follow-Up 
 
A version of this chapter has previously been published: 
Knight E, Petrella RJ. Prescribing physical activity for healthy aging: Longitudinal mixed 
method analysis of an intervention through primary care. The Physician and 
Sportsmedicine. 2014;42(4):30-38. doi: 10.3810/psm.2014.11.2089. 
 
4.1 Abstract 
Background: There is a shortage of literature describing the experience of individuals 
who have participated in a physical activity and mobile health (mHealth) intervention. 
Many physical activity interventions are of short duration and do not report long-term 
changes in clinical measures or adoption of prescribed health behaviours. Previously, we 
have reported the clinical and behavioural outcomes from the first phase of a physical 
activity prescription and mHealth intervention delivered through the primary care setting. 
The purpose of this next phase was to perform a longitudinal follow-up six-months post-
intervention. 
Methods: Mixed methods analysis including repeated measures ANOVA of functional 
aerobic capacity (VO2max) at pre-intervention, post-intervention, and follow-up clinic 
visits, and whole text analysis of semi-structured interviews discussing the participant 
experience in a health behaviour intervention. 
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Results: Twenty participants, mean age 63 ± 5 years, participated. Gains made in 
VO2max were maintained at 6 months (p < 0.05). Participants reported engaging in 
sustained and routine physical activity, yet some identified a need for additional support 
to adopt the prescribed health behaviours. Emergent themes included the desire for short-
term mHealth intervention to educate individuals about prescribed health behaviours 
without need for ongoing management by clinicians, leveraging mHealth to build social 
networks around prescribed health behaviours and to connect individuals to build a sense 
of community, and participant views of physical activity as medicine. 
Conclusions: The present study investigated both the long-term adoption of physical 
activity behaviours as well as the participant experience in a physical activity and 
mHealth intervention. Findings from the current study may be used to inform the 
development of user-centered lifestyle interventions. 
 
Keywords: mixed methods; mobile health; activity prescription; healthy aging; disease 
prevention; Exercise Is Medicine  
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4.2 Introduction 
Health systems around the world are progressively being dominated by the need to care 
for chronic conditions and non-communicable diseases.1,2 In the years to come, it is 
projected that deaths due to chronic and non-communicable disease will account for 
nearly 60% of disease burden globally.1 Simultaneously, life expectancies in developed 
countries are increasing by approximately two years each decade.3 The prevalence of 
chronic conditions increases with advanced age.4,5 Therefore, a disparity remains between 
longevity and independent healthy living.6 It is crucial that user-centered programs and 
services be developed and implemented to facilitate the adoption of healthy living 
behaviours now to promote healthy, independent aging.  
 
4.2.1 Physical Activity 
It is well reported in the literature that physically active lifestyles promote health and 
healthy aging. However, the majority of North American adults are not meeting 
minimum physical activity levels recommended in public health guidelines.7-10 Physical 
inactivity is the fourth leading cause of death, and each year contributes to more than 
three million deaths around the world.11 Health messages delivered in the primary care 
setting can be a catalyst for change.12,13 A written prescription represents the value a 
health practitioner (e.g. physician) places on exercise for managing and promoting 
health.14 Moreover, the global expansion of Exercise Is Medicine®15 initiatives 
demonstrate the widespread acceptance of the prescription of exercise to manage and 
prevent lifestyle-related diseases.  
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4.2.2 mHealth 
There is a growing body of evidence reporting the power and utility of mobile 
communication devices in the health landscape (i.e. mobile health [mHealth]). The 
worldwide omnipresence of mobile communication devices supports the availability of 
mHealth for comprehensive and frequent data sharing.16,17 Mobile technologies are 
becoming a focus for chronic disease management and prevention, and reportedly 
improve access to information and services, provide care that is not otherwise 
deliverable, and increase care delivery.18,19 Therefore, mHealth holds the potential to 
engage patients in ongoing treatment for and self-management of their health. 
 
4.2.3 Research Paradigm 
Pragmatic approaches to research leverage the strengths of quantitative and qualitative 
research paradigms in an effort to consider multiple perspectives and viewpoints in a 
unified approach. This methodology is often referred to as triangulation, and focuses on a 
mixture, or balance, of qualitative and quantitative research paradigms.20 Understanding 
the experience of individuals who have participated in research investigating the 
implementation of prescribed changes in health behaviours is fundamental to designing 
future interventions, programs, and services that respond to patient needs. Leveraging the 
experience of individuals to develop better systems is at the core of user-centered 
design.21 However, there has been a shortage of information describing the experience of 
individuals who have participated in a physical activity and mHealth intervention.  
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4.2.4 Objective 
Previously, we have reported the clinical and behavioural outcomes from the first phase 
of a physical activity prescription and mHealth intervention delivered through the 
primary care setting.12,22 Briefly, the 12-week intervention elicited significant changes in 
anthropometrics (body mass index, waist circumference), functional aerobic capacity 
(predicted maximum oxygen consumption [VO2max]), and clinical markers for 
cardiometabolic risk (blood pressure, glucose, cholesterol),12 as well as self-monitored 
measures of physiological and behavioural risk factors for cardiovascular disease 
(physical activity, blood pressure, blood glucose, body weight).22 The purpose of this 
next phase was two-fold: (1) determine if improvements made through the 12-week 
intervention phase were maintained long-term by measuring a clinical marker of 
cardiometabolic health risk (functional aerobic capacity) at six months post-intervention; 
and (2) discuss with participants their experience in a behavioural health intervention to 
elicit themes describing the participant experience in a program aimed to modify lifestyle 





Individuals enrolled in the 12-week intervention were invited to complete a longitudinal 
follow-up visit 6 months post-intervention. The intervention is described elsewhere.12,22 
Briefly, participants were randomized into four groups based on the prescribed level of 
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physical activity intensity: no prescription (control), increasing high-intensity activity 
(i.e. exercise), reducing low-intensity activity (i.e. sedentary behaviour), or both 
(increasing exercise and reducing sedentary behaviour). Participants in the three groups 
receiving an activity prescription at baseline also received a technology kit of mHealth 
devices for home self-monitoring of risk factors associated with cardiometabolic disease, 
including blood pressure, blood glucose, body weight, and physical activity. During the 
pre-intervention visit (week 0) the activity prescription included counselling with a 
Certified Exercise Physiologist (CSEP-CEP®) and a personalized activity program. At 
the post-intervention visit (week 12), all participants were provided with a written 
prescription indicating their VO2max, target training heart rate, and amount of activity 
required to meet physical activity guidelines (Figure 4.1). Participants were not informed 
during the 12-week visit that they would be contacted six months later for a longitudinal 
follow-up visit.  
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Figure 4.1 Standardized Prescription Form from the Step Test and Exercise 
Prescription (STEP™) Tool 
Reproduced from Critical Reviews in Physical and Rehabilitation Medicine,23 license No. 
3313140624563, with permission of Begell House Inc. 
 
At the follow-up visit (after 36 weeks), participants completed the submaximal self-paced 
functional aerobic capacity test from the Step Test and Exercise Prescription (STEP™)24-
26 tool as well as engaged in a semi-structured interview discussing their experience in the 
mHealth and physical activity intervention.  




Sixty older men and women (aged 55 to 75 years) volunteered for the 12-week 
intervention. They were invited to attend the follow-up visit using their preferred method 
of communication (e.g. email, telephone). Two attempts were made to contact each 
participant for this follow-up visit. Exclusion criteria from the first phase were followed, 
which are reported elsewhere.12,22 All subjects provided informed written consent as 
approved by Western University Health Sciences Research Ethics Board (Protocol No. 
18700). 
 
4.3.3 Statistical Analysis 
4.3.3.1 Quantitative Analysis 
Previously, we found no difference between groups for functional aerobic capacity 
(VO2max) during the 12-week intervention phase.12 A dependent samples t-test was 
conducted to test for differences in VO2max between participants who completed follow-
up (36-week) testing and participants who completed post-intervention (12-week) testing 
only. Repeated measures ANOVA was conducted for the primary outcome (VO2max). 
Analyses were conducted in IBM SPSS® Statistics Version 20 (Chicago, IL). Data are 
presented as mean (± standard deviation).  
4.3.3.2 Qualitative Analysis 
Interviews were digitally recorded and manually transcribed by the first author. Member 
checking was conducted by reading the transcript back to the participant to confirm that it 
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reflected the message and tone that the participant intended to convey. Whole text 
analysis27 was conducted to interpret participant responses. Data were managed in 





Of the 60 participants invited to participate, 30 (50%) did not respond to the invitation, 
four declined (7%), and 26 (43%) were interested. Twenty participants (12 women and 8 
men) volunteered to participate in the longitudinal follow-up visit. The mean age of 
participants at follow-up was 63 ± 5 years. 
 
4.4.2 Quantitative Results 
The average functional aerobic capacity of the sample across the 3 clinic visits are 
presented in Table 4.1. There was no difference in VO2max between participants who 
completed the longitudinal follow-up visit and those who did not participate (p = 0.250). 
There was a significant change in aerobic capacity (F(2,38) = 13.645, p<0.01, ηp2 = 0.418). 
Post-hoc analysis using a Greenhouse-Geisser correction indicated that the difference was 
significant between pre-intervention (week 0) and post-intervention (week 12) visits, with 
no difference between post-intervention and follow-up (after 36 weeks) visits (Figure 
4.2). The unpublished standard error associated with VO2max calculation from the 
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STEP™ tool is 1.35. Therefore, gains made through the intervention (12 weeks) and 
sustained to follow-up (36 weeks) may be considered significant. Results from the 
current study are promising, given that longitudinal follow-up from previous STEP™-
based interventions have demonstrated that gains made in VO2max at six months were 
maintained to ≥ 12 months.13 
 
Table 4.1 Average Aerobic Capacity Across 3 Clinic Visits (n=20) 
Clinic	  visit	   VO2max	  
(ml/kg/min)	  
Week	  0	   29.91	  ±	  7.94	  
After	  12	  weeks	   33.02	  ±	  6.46	  
After	  36	  weeks	   33.59	  ±	  6.99	  
Note: Data presented as mean ± standard deviation. 
Abbreviation: VO2max, functional aerobic capacity (maximum oxygen consumption). 
 
Figure 4.2 Aerobic Capacity Across 3 Clinic Visits (n=20) 
Note: * denotes statistical difference (p < 0.05). 




4.4.3 Qualitative Results 
4.4.3.1 Activity Prescription 
The physical activity prescription portion of the intervention is described elsewhere.12 
Briefly, at baseline participants in the intervention groups were provided with 
personalized activity programming through a written activity prescription. At 12 weeks 
all participants received a written prescription identifying their predicted aerobic capacity 
(VO2max), corresponding fitness level, and information regarding their target training 
intensity, frequency, type, and time (Figure 4.1).  
 
At the longitudinal follow-up, participants were asked if they had continued doing their 
activity prescription from the intervention after their final clinic visit (six months 
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previously). Representative quotations of participants’ responses are listed in Table 4.2. 
The responses suggested that most participants who did continue their activity 
prescription adapted it to their evolving activity preferences and lifestyle needs to 
maintain health benefits. Moreover, participants reported that they had successfully 
incorporated healthy physical activity behaviours into their daily routines. However, 
some participants reported obstacles to engaging in sustained healthy activity behaviours 
following the 12-week intervention period. Common themes for not continuing with their 
personal activity prescription included weather/seasonal, lack of purpose after the study 
ended, and medical reasons preventing engagement in activity. 
 
Table 4.2 Participants' Comments About the Activity Prescription 
“I	  would	  say	  that	  I	  do	  it	  regularly,	  but	  it’s	  altered	  in	  terms	  of	  the	  exercise	  I’m	  doing.	  I’ve	  sort	  of	  
evolved.”	  (61-­‐year-­‐old	  man)	  
“I	  just	  go	  day-­‐by-­‐day.	  It	  depends	  on	  what	  I	  have	  on	  the	  agenda…	  I	  have	  my	  events	  and	  my	  
outings,	  and	  I	  plan	  [activity]	  around	  them.”	  (65-­‐year-­‐old	  woman)	  
“Yes.	  Just	  continue	  to	  do	  what	  I’m	  doing	  at	  the	  gym:	  my	  walking,	  working	  with	  the	  weights,	  
going	  on	  the	  treadmill,	  not	  to	  sit	  too	  long.”	  (62-­‐year-­‐old	  man)	  
“It’s	  just	  a	  commitment	  to	  myself	  to	  do	  activity	  everyday	  like	  we	  planned	  [in	  the	  study].	  It’s	  
really	  the	  commitment	  to	  myself,	  determination	  to	  stay	  in	  shape.”	  (57-­‐year-­‐old	  woman)	  
“Yeah,	  I	  did	  in	  the	  summertime.	  Just	  wintertime,	  sometimes	  I	  go	  to	  the	  YMCA	  and	  work	  with	  the	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machine,	  but	  not	  walking	  [outside].	  In	  the	  summer	  I	  will	  go	  and	  do	  it	  again.”	  (59-­‐year-­‐old	  man)	  
“I	  found	  it	  very	  helpful,	  you	  know.	  I	  think	  it	  gave	  us	  a	  purpose	  to	  do	  it.	  It	  was	  a	  useful	  tool	  and	  
we	  tried	  to	  keep	  up,	  but	  I	  don’t	  think	  we’re	  keeping	  up	  as	  much	  because	  you’re	  not	  sort	  of	  
checking-­‐in	  and	  putting	  in	  the	  numbers	  [self-­‐monitoring]	  and	  that.	  We	  had	  more	  of	  a	  purpose	  
while	  we	  were	  doing	  the	  study.”	  (63-­‐year-­‐old	  couple)	  
“I	  would	  need	  someone	  to	  keep	  track	  of	  me.	  The	  accountability.”	  (59-­‐year-­‐old	  woman)	  
“I	  have	  not	  been	  doing	  the	  walking	  like	  I	  should	  as	  my	  knee	  has	  been	  hurting	  all	  winter.	  I	  have	  




In addition to the physical activity prescription, the intervention also included an mHealth 
component (described elsewhere22). Briefly, participants were provided with a 
technology kit including a smartphone, blood pressure monitor, glucometer, pedometer, 
and weight scale to submit health measures remotely during the 12-week intervention. At 
the longitudinal follow-up, participants were asked about their experience using the 
technology kit, and if they would like to use any of the devices on an ongoing basis. 
Representative quotations of participants’ responses are listed in Table 4.3.  
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Table 4.3 Participants' Comments About mHealth 
“I	  found	  it	  quite	  helpful,	  really.	  I	  went	  out	  and	  got	  my	  own	  blood	  pressure	  cuff.	  I	  already	  had	  a	  
pedometer.	  I	  weigh	  myself	  when	  I	  go	  to	  the	  gym,	  probably	  once	  a	  week.	  I	  have	  a	  glucometer	  
now,	  and	  it’s	  helpful	  because	  times	  when	  I	  think	  it’s	  going	  to	  be	  high	  it’s	  not.	  So	  I’ve	  got	  my	  own	  
everything	  now.	  I	  just	  monitor	  them.	  If	  I	  find	  out	  my	  sugar’s	  high,	  I	  think	  about	  what	  I	  had	  to	  eat.	  
Then	  I	  know	  not	  to	  eat	  it	  again,	  or	  eat	  less	  of	  it.”	  (62-­‐year-­‐old	  man)	  
“Very	  helpful,	  I	  found.	  Encouraging	  to	  see	  good	  blood	  pressure,	  sugar	  glucose	  go	  down.	  Using	  it	  
would	  be	  good.	  I	  would	  use	  it	  if	  I	  had	  it—maybe	  not	  every	  day.	  I	  might	  buy	  them	  myself.	  I	  
thought	  about	  getting	  a	  blood	  pressure	  thing,	  but	  I	  don’t	  want	  to	  get	  too	  addicted	  to	  it	  though,	  
that’s	  the	  thing.	  “Self-­‐management”:	  I’d	  never	  thought	  of	  it	  like	  that	  before	  [the	  study].”	  (57-­‐
year-­‐old	  woman)	  
“I	  did	  buy	  the	  pedometer	  after	  the	  study.	  I	  already	  had	  a	  blood	  pressure	  machine.	  I	  didn’t	  
bother	  with	  the	  glucose.	  I	  log	  measures	  about	  a	  month	  before	  my	  annual	  check-­‐up.	  For	  the	  
pedometer,	  I	  don’t	  log	  it	  but	  I	  make	  sure	  each	  day	  I	  do	  a	  decent	  amount.”	  (73-­‐year-­‐old	  woman)	  
	  “I	  enjoyed	  the	  pedometer.	  It	  gave	  me	  motivation	  to	  try	  and	  outdo	  the	  number	  of	  steps.	  Even	  
my	  neighbor	  wanted	  to	  know	  how	  many	  steps	  we	  did	  together	  on	  walks.	  I	  also	  liked	  finding	  the	  
correlation	  between	  doing	  the	  activities	  and	  sleeping	  much	  better	  at	  night.	  That	  was	  a	  really	  
good	  correlation—I	  liked	  that!	  Even	  when	  I	  went	  [on	  vacation]	  I	  did	  my	  exercise	  because	  they	  
had	  an	  exercise	  room.”	  (65-­‐year-­‐old	  woman)	  
“I	  think	  the	  most	  important	  thing	  is	  the	  pedometer.	  This	  is	  the	  BEST	  device.	  You	  can	  talk	  about	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all	  kinds	  of	  other	  things,	  but	  this	  one	  is	  the	  best	  because	  you	  know	  what	  you	  did	  and	  you’re	  
always	  trying	  to	  compete	  and	  to	  keep	  it	  up	  and	  set	  a	  goal	  and	  then	  just	  go	  for	  it.”	  (68-­‐year-­‐old	  
woman)	  
“No,	  it	  wasn’t	  a	  burden	  for	  me.	  It	  just	  makes	  you	  aware	  of	  your	  blood	  pressure	  and	  blood	  
sugars.	  I	  thought	  mine	  were	  levels	  that	  were	  fine	  anyway.	  But	  you	  know,	  it	  just	  gives	  it	  to	  you	  
right	  there	  [on	  device	  screen].	  Somebody	  who	  had	  issues,	  it	  might	  be	  more	  important	  for	  them	  
because	  they	  can	  see	  it	  [measures]	  there	  clearly.	  Whereas	  I’m	  fortunate	  to	  not	  have	  issues.	  So,	  
you	  know.	  I	  really	  enjoyed	  the	  pedometer—it	  was	  the	  one!	  The	  blood	  pressure	  and	  sugars,	  you	  
know.	  I	  really	  liked	  that	  pedometer.”	  (65-­‐year-­‐old	  woman)	  
“It	  was	  helpful,	  yeah.	  It	  was	  a	  little	  bit	  hard,	  but	  helpful.	  At	  first	  I	  start,	  and	  yeah,	  had	  a	  little	  bit	  
problems.	  But	  after	  like	  2	  weeks	  it	  was	  easy.”	  (59-­‐year-­‐old	  man)	  
“It	  was	  a	  burden.	  I	  found	  that	  I	  would	  get	  upset.	  I	  don’t	  know	  why,	  but	  anytime	  I	  have	  to	  do	  
anything	  that	  just	  raises	  my	  tension	  or	  stress,	  you	  now.	  It	  definitely	  isn’t	  good	  for	  my	  blood	  
pressure!	  The	  other	  parts	  were	  fine,	  like	  sending	  in	  blood	  sugar,	  I	  guess.	  I	  do	  take	  my	  blood	  
sugar	  every	  day	  so	  it’s	  not	  a	  big	  deal.	  But	  if	  it	  didn’t	  go	  right	  the	  first	  time	  I	  took	  it,	  then	  I’d	  do	  it	  
again	  and	  the	  machine	  would	  beep.	  There	  was	  a	  delay	  in	  the	  machine—it	  didn’t	  happen	  
instantly,	  so	  I	  was	  worried.	  And	  the	  same	  thing	  when	  I	  recorded	  my	  steps:	  sometimes	  it	  didn’t	  
seem	  like	  it	  went	  through.	  But	  I	  found	  out	  it	  did,	  so	  I	  ended	  up	  sending	  it	  in	  a	  couple	  of	  times.	  So	  
there	  are	  those	  hassles.	  But	  if	  someone	  HAD	  to	  use	  it,	  it	  would	  be	  okay.”	  (68-­‐year-­‐old	  woman)	  
“I	  think	  it	  was	  helpful.	  Prior	  to	  that	  I	  wouldn’t	  be	  able	  to	  tell	  you	  what	  my	  heart	  rate	  normally	  is.	  
And	  now	  I	  know	  the	  range	  it’s	  in,	  as	  well	  as	  my	  blood	  glucose	  and	  weight.	  Probably	  before	  the	  
study	  if	  someone	  asked	  me	  what	  my	  weight	  was	  I’d	  just	  say	  I	  really	  don’t	  know.	  Because	  my	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readings	  were	  so	  consistent	  through	  the	  study,	  it	  was	  good	  to	  have	  that	  period	  of	  time,	  but	  I	  
don’t	  think	  I	  would	  continue	  to	  use	  it	  just	  because	  they	  are	  so	  consistent.	  You	  know,	  now	  when	  I	  
go	  to	  my	  physician	  I	  have	  an	  expectation—so	  being	  able	  to	  kind	  of	  monitor,	  I’ve	  got	  a	  
benchmark	  now”	  (54-­‐year-­‐old	  man)	  
“I	  was	  encouraged	  by	  having	  it	  all	  measured.	  My	  workouts	  are	  a	  lot	  harder	  now	  that	  I	  know.	  I	  
feel	  good	  about	  pushing	  hard	  now	  because	  of	  it.	  I	  guess	  it’s	  that	  old	  adage	  in	  business:	  what	  
doesn’t	  get	  measured	  doesn’t	  get	  done.	  You	  need	  that	  feedback.”	  (61-­‐year-­‐old	  man)	  
“I	  think	  the	  [self-­‐monitoring	  feedback]	  was	  really	  valuable:	  it	  shows	  us	  that	  we	  did	  it,	  and	  this	  is	  
where	  we	  are	  now.”	  (63-­‐year-­‐old	  couple)	  
	  “I	  was	  interested	  in	  the	  subject—myself!—and	  general	  health.	  And	  I	  didn’t	  know	  a	  lot	  about	  my	  
glucose,	  which	  it	  turns	  out	  is	  pretty	  flat	  and	  regular	  so	  that’s	  good.	  I	  thought	  it	  was	  a	  pretty	  
useful	  tool.	  I	  think	  the	  feedback	  is	  good.	  I	  should	  be	  monitoring	  my	  blood	  pressure	  a	  little	  more	  
because	  I	  tend	  to	  get	  readings,	  like,	  all	  over	  the	  place.	  When	  I	  went	  to	  the	  doctor	  last	  month,	  
those	  were	  the	  best	  [blood	  pressure]	  readings	  I’ve	  had	  in	  years.”	  (61-­‐year-­‐old	  man)	  
 
The responses indicated that the participants enjoyed learning how to use the technology 
for self-management, did or would like to continue using the devices, and that they 
typically found some devices more appropriate to their health and lifestyle needs than 
others. Specifically, the pedometer was most commonly reported as a useful device for 
self-monitoring. However, participants with multiple health concerns were interested in 
sustained use of additional devices, such as the blood pressure and blood glucose 
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monitors and the weight scale. Few participants reported interest in using the smartphone 
for ongoing self-monitoring of health measures. 
 
Among this older adult sample, for some participants the technology kit was their first 
introduction to a smartphone and to mHealth devices. Participants were asked about their 
experience learning to use these devices. Most responses indicated that learning to use the 
devices was easy, and that using the devices was unobtrusive to their daily routines. 
However the few participants who struggled with the technology kit shared details of 
their experience identifying various challenges, which included the usability of the 
various devices in the kit as well as device integration with the health application used to 
manage submitted measures. The participants also reported that using the technology 
during the intervention period was sufficient to provide them with a more comprehensive 
understanding of their health, which suggests that mHealth devices may have a role in 
educating individuals without the need for ongoing clinician-supported intervention. 
Participants reported that using the mobile technology kit for self-management was 
especially useful due to the instant feedback. Figure 4.3 demonstrates the instant 
feedback available through the smartphone application, which displays graphical and 
tabular results for the participants to view. Tables reported each submitted measure, and 
graphs displayed trends in submitted measures over time. Individual tables and graphs 
were generated in real time for each measure (physical activity, blood pressure, blood 
glucose, and body weight). Additionally, participants had access to all their wirelessly 
submitted measures during the course of the intervention. Some participants reported 
sharing this information with their personal healthcare team (e.g. primary and allied 
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health professionals), and some participants capitalized on the graphs and figures 
generated as well as their experience in taking and submitting measures to learn about 
and manage their health.  
 
Figure 4.3 Graphical Feedback for Self-Monitoring 
 
 
4.4.3.3 Education About Health 
Beyond the two principal components of the intervention (activity prescription and 
mHealth), there was interest in assessing how participating in this intervention educated 
the participants about health and activity behaviours. During the interview, participants 
were asked if there was something specific that they learned during the intervention that 
they continue to use in their daily life on an ongoing basis. Representative quotations of 
!
!
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participants’ responses are listed in Table 4.4.  Interview responses indicated that 
participants now have an understanding of their personal activity behaviours relative to 
evidence-based guidelines. Moreover, the physical activity counseling process was cited 
as a beneficial learning experience for individuals by enhancing their knowledge of and 
confidence with physical activity and exercise.  
 
Table 4.4 Participants' Comments About Health Education 
“I	  think	  for	  me,	  and	  probably	  for	  both	  of	  us,	  it’s	  just	  an	  awareness	  of	  knowing	  what	  we	  need	  to	  
do.	  It	  was	  recommended	  when	  we	  started	  to	  get	  the	  10,000	  steps.	  So	  that’s	  really	  the	  
benchmark	  we	  use.	  I	  think	  the	  whole	  program	  gave	  both	  of	  us	  a	  better	  awareness.	  We	  used	  to	  
go	  for	  walks,	  but	  now	  we’re	  more	  aware	  of	  going	  a	  little	  further	  and	  going	  a	  little	  faster.”	  (63-­‐
year-­‐old	  couple)	  
“I	  learned	  that	  you’ve	  got	  to	  get	  that	  activity	  in	  every	  day.”	  (67-­‐year-­‐old	  woman)	  
“I	  probably	  take	  the	  stairs	  more	  at	  work.	  Just	  integrate	  more.	  Or	  if	  I’m	  working	  at	  my	  desk	  I’ll	  get	  
up	  and	  instead	  of	  having	  coffee	  in	  the	  kitchen	  on	  my	  floor	  I’ll	  go	  up	  2	  floors	  and	  get	  a	  coffee	  on	  
the	  other	  floor.”	  (58-­‐year-­‐old	  woman)	  
“It	  was	  the	  fact	  that	  10,000	  steps	  is	  a	  good	  target.	  And	  I	  wear	  the	  pedometer.	  And	  if	  I	  haven’t	  
done	  the	  10,000	  steps	  in	  the	  day,	  I	  know	  why.	  And	  most	  of	  the	  time	  when	  I	  haven’t,	  I	  haven’t	  
been	  idle:	  I’m	  on	  my	  feet,	  I’m	  ironing,	  I’m	  cooking—so,	  active	  in	  that	  sense.	  In	  fact,	  when	  I’ve	  
read	  a	  book	  I	  think,	  ‘Oh	  darn	  it,	  I	  have	  to	  get	  up	  and	  get	  moving!’”	  (64-­‐year-­‐old	  woman)	  
“Well,	  actually,	  I	  think	  the	  talk	  we	  had	  about	  how	  to	  exercise,	  and	  particularly	  the	  weight	  lifting,	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I	  found	  really,	  really	  helpful.	  And	  I’ve	  used	  it	  a	  lot.	  The	  strategies	  and	  techniques	  and	  pointers	  
you	  pointed	  out.	  The	  way	  we	  talked	  about	  it.	  And	  just	  doing	  it	  regularly,	  I	  guess.	  I	  think	  really	  for	  
the	  first	  time	  in	  my	  life	  it’s	  not	  a	  chore.	  I’m	  not	  looking	  for	  excuses	  anymore.	  A	  more	  measured	  
approach,	  you	  know	  what	  I	  mean.	  And	  that,	  I	  guess,	  comes	  from	  really	  a	  lifestyle	  change	  instead	  
of	  sort	  of	  saying	  something	  like	  I’m	  going	  to	  lose	  weight	  or	  exercise	  for	  6	  weeks.	  I	  just	  got	  into	  
the	  routine	  of	  making	  it	  part	  of	  my	  day,	  and	  now	  it	  is.”	  (61-­‐year-­‐old	  man)	  
 
4.4.3.4 Exercise as Medicine 
The participants’ comments during the interviews illustrated their perceptions of exercise 
and activity as a form of medical treatment, perhaps because the intervention was 
initiated in the primary care setting, or because the participants in the intervention groups 
were measuring markers of health at home for the 12-week intervention period. 
Representative quotations of participants’ responses are listed in Table 4.5; specific 
references to exercise as medicine are italicized.   
 
Table 4.5 Participants' Comments About Exercise as Medicine 
Note: Specific references to exercise as medicine are italicized. 
“I	  should	  tell	  you	  too,	  that	  my	  blood	  sugar	  has	  gone	  way	  down.	  They	  say	  that	  exercise	  is	  good	  for	  
managing	  it.	  And	  since	  the	  study	  it’s	  gone	  down	  to	  a	  lower	  level	  where	  I	  don’t	  have	  to	  worry	  
about	  it	  anymore.	  So	  that’s	  good.”	  (68-­‐year-­‐old	  woman)	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“Because	  you	  feel	  better—that’s	  probably	  my	  motivation.”	  (57-­‐year-­‐old	  woman)	  
“I	  learned	  that	  when	  I	  thought	  I	  was	  taking	  sufficient	  exercise	  I	  wasn’t:	  that	  the	  time	  I	  was	  on	  the	  
treadmill	  for	  wasn’t	  enough.	  Some	  days	  I	  was	  only	  at	  5	  [thousand	  steps],	  and	  I	  got	  on	  the	  
treadmill	  and	  thought,	  ‘I	  don’t	  care	  how	  long	  it	  takes	  me,	  I’m	  going	  to	  get	  that	  10	  in’	  or	  as	  close	  
as	  I	  can.	  Before	  the	  study,	  if	  my	  time	  on	  the	  treadmill	  got	  interrupted	  I	  would	  just	  let	  it	  go.	  But	  
now	  I	  know	  I	  need	  to	  go	  back	  down	  and	  do	  more	  time	  to	  finish	  it.”	  (73-­‐year-­‐old	  woman)	  
“My	  doctor	  actually	  told	  me	  that	  if	  I	  wasn’t	  doing	  what	  I’m	  doing	  now	  I	  would	  have	  high	  blood	  
pressure	  and	  diabetes	  because	  they	  run	  in	  the	  family.	  He	  told	  me	  to	  keep	  doing	  what	  I’m	  doing	  
because	  I’m	  looking	  after	  myself	  and	  really	  medicating	  myself	  with	  exercise.”	  (57-­‐year-­‐old	  
woman)	  
 
4.4.3.5 Building Community and Social Networks 
At the follow-up visit we learned that some participants were in common social networks 
outside the study. Group participation and networking was not an intentional component 
of this intervention. However, participants commented on the value of building a sense of 
social network or community through mHealth devices and participating in activities with 
health professionals and with other individuals. Representative quotations of participants’ 
responses are listed in Table 4.6.  
 
   
116 
Table 4.6 Participants' Comments About Building Community and Social Networks 
“I	  would	  like	  to	  be	  informed.	  Like	  if	  you	  find	  out	  about	  a	  new	  food	  or	  something	  that’s	  good,	  just	  
to	  send	  out	  an	  email	  to	  everyone	  to	  share	  it.”	  (58-­‐year-­‐old	  woman)	  
“My	  friend	  came	  into	  the	  study	  too,	  and	  it	  was	  nice	  to	  have	  someone	  to	  talk	  to	  about	  it,	  
understand	  why	  you	  were	  doing	  it	  and	  had	  the	  same	  motivations...”	  (65-­‐year-­‐old	  woman)	  
“Just	  knowing	  other	  people	  were	  in	  the	  study	  was	  fun.	  Whenever	  we’d	  chat	  we’d	  say,	  ‘So,	  how	  
many	  steps	  have	  you	  done?’	  A	  bit	  of	  a	  competition.	  So	  that	  was	  good.	  It	  was	  fun.”	  (64-­‐year-­‐old	  
woman)	  
“My	  physical	  activity	  actually	  impacts	  my	  wife’s.	  Because	  a	  number	  of	  times	  of	  doing	  those	  
walks,	  she’s	  doing	  those	  walks	  with	  me.”	  (62-­‐year-­‐old	  man)	  
 
4.5 Discussion 
The purpose of this mixed methods study was both to assess long-term changes in aerobic 
fitness following a 12-week physical activity and mHealth intervention and to gain a 
better understanding of the participants’ experience in a health behaviour intervention. 
Understanding the lived experience of individuals may enhance the design of future 
interventions, programs, and services by focusing on a user-centered approach. 
Moreover, testing the long-term clinical improvements helps to support the importance of 
assessing cardiorespiratory fitness in the primary care setting for chronic disease 
management and prevention. 
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Previously it has been suggested that, independent of the type of intervention, there is a 
tendency for behaviours to return to baseline following intervention.28 Aerobic capacity 
(VO2max) reduces in as little as three weeks without continued training.29 However, 
previous STEP™-based interventions have reported that gains made in aerobic capacity 
at six months were maintained ≥ 12 months.13 Quantitative results from the present study 
demonstrate that gains made in functional aerobic capacity through the intervention were 
maintained to six months. Results are promising in that they demonstrate long-term 
adoption of behaviours prescribed through the physical activity intervention. 
 
Quantitative results should be interpreted with caution due to the small sample size. Only 
one third of the participants from the 12-week intervention participated in the long-term 
follow-up measure of functional aerobic capacity. Participants were not informed at the 
end of the 12-week intervention that they would be contacted again in 6 months to 
participate in a follow-up visit. Therefore, it is perhaps not surprising that half of the 
original sample did not respond to the attempts to contact for this phase of the study. 
However, there was no difference in aerobic capacity post-intervention between 
participants who chose to participate in the follow-up and participants who did not 
choose to participate. Results demonstrate the maintenance of functional aerobic capacity 
6 months following intervention, which may support the clinical utility of providing a 
written physical activity prescription through the primary care setting to help individuals 
maintain healthy living behaviours. These results support evidence-based approaches to 
exercise prescription through primary care, such as Exercise Is Medicine®.15 
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Although weather, illness, and lack of accountability are commonly reported reasons for 
not engaging in physical activities, what is interesting from the current study is that these 
reasons remained barriers to participation even after individuals received a written 
exercise prescription and completed a 12-week physical activity intervention. In contrast, 
previously it had been suggested that receiving a written prescription for physical activity 
from a health care professional can be a catalyst for change.13,14 Future studies may wish 
to consider phase-out periods following the intervention during which individuals receive 
additional programming and guidance to help facilitate a successful transition out of the 
study and into incorporating sustained healthy behaviours in their daily routine.  
 
Adherence to self-report of health measures via mobile device decreases over time.30 
Similarly, a theme that emerged in the present study was that using mHealth devices for a 
period of time was acceptable, but that long-term use was not desired by all. Thus, mobile 
devices may have benefit as educational tools for short-term intervention to initiate 
behaviour changes without the demand for ongoing support. Future investigations need to 
explore if a short-term intervention period using mHealth tools to initiate treatment 
programs and prescribed health behaviours is sufficient for sustaining adoption of healthy 
behaviours and management of disease risk. This approach may be supported by 
clinicians, as it has the potential to shift the responsibility for ongoing management and 
prevention to the patient.  
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Physical activity interventions that are designed to reflect the needs of the target 
population must incorporate an understanding of the lived experiences of the participants. 
From a user-centered design approach, it is the combination of theory, user needs, and the 
evidence base that contributes to the design of responsive programs and services.21 
Previous research has shown that remote monitoring technologies enable participants to 
share in responsibility for their own health, while also providing a new understanding of 
their overall health and physical fitness,31 which is further supported by results from the 
present study. Moreover, although some individuals were able to incorporate prescribed 
physical activity behaviours into their daily routines, others identified a need for more 
assistance to adopt a healthy, active lifestyle.  
 
4.5.1 Conclusion 
The present study investigated both the long-term adoption of physical activity 
behaviours as well as the participant experience in a physical activity and mHealth 
intervention. The intervention improved functional aerobic capacity (VO2max), which 
was maintained long-term. Although many participants reported engaging in sustained 
and routine physical activities following initial intervention, some reported a need for 
continued support to adopt the prescribed health behaviours. Barriers that prevented 
sustained engagement in physically active lifestyles included health problems, weather, 
and a lack of purpose following the study. The sample of older adults enjoyed the 
mHealth component, reported new awareness of evidence-based guidelines for healthy 
active living following the intervention, and indicated that ongoing self-monitoring 
would be best using devices specific to their health needs and personal preferences. 
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Emergent themes included the need for short-term mHealth intervention to educate 
individuals about prescribed health behaviours without entailing ongoing support or 
management by clinicians, that mHealth could be used as a platform to build social 
networks around prescribed health behaviours to connect individuals and build a sense of 
community, as well as participants’ views of physical activity as a form of health risk 
management. Findings from the current study can be used to inform the development of 
user-centered lifestyle interventions.  
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Chapter 5 
5 Discussion  
In developed countries, adults are living longer than previous generations.1 Currently, this 
increased life expectancy is paired with increased prevalence of chronic conditions.2,3 For 
centuries we have understood the importance of physical activity in promoting health.4,5 
Despite this, only 13% of Canada’s older adults engage in sufficient levels of physical 
activity.6 Physical inactivity is a preventable risk factor for many chronic conditions 
including cardiovascular disease, diabetes, cancer, hypertension, obesity, depression and 
osteoporosis.7 Older adults are at greater risk for sedentary lifestyles,8 and Canadian 
adults over 60 years of age accumulate more sedentary behaviour than their younger 
counterparts, regardless of sex.6 This suggests that older adults are at increased risk for 
the health consequences of a sedentary lifestyle. Therefore, interventions aimed at 
changing physical activity behaviours among this population are warranted. 
 
5.1 Intervening on Physical Activity Behaviours 
Interrupting prolonged sedentary time, such as by standing up, may be a feasible 
approach for intervention, and may be a reasonable alternative to prolonged sitting 
especially among physically inactive individuals.9 While both sitting and standing seem 
like simple behaviours, they are in fact distinct behaviours.9 Compared to increasing time 
spent engaged in moderate- to vigorous-intensity physical activity (MVPA), reducing 
sedentary time is conceptually an easier behaviour to change. This may contribute to 
successful intervention approaches and be more effective at changing behaviours than 
exercise or combined approaches. However, this is an area of research that is still 
developing. 
 
A recent systematic review by Prince et al10 examined the effect of physical activity 
interventions on sedentary behaviours. Results demonstrated that changing behaviours 
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along the activity spectrum (sedentary through MVPA) can result in small, yet 
significant, reductions in sedentary time: approximately 20 minutes less per day.10 
Interestingly, interventions targeting both sedentary and MVPA can result in even more 
substantial reductions in sedentary time: approximately 35 minutes/day less sedentary 
time.10 These results demonstrate that interventions designed to include physical activity 
behaviour change of any intensity (sedentary through MVPA) would be expected to 
result in reduced sedentary time. However, it should be noted that the studies included in 
this systematic review predominantly focused on changing sitting time at work, not 
sedentary lifestyles in the free-living environment. Moreover, the authors highlight that 
the quality of studies to-date is “moderate” due to small numbers and large heterogeneity. 
Therefore results should be interpreted with caution, but are promising in that they 
suggest that intervening on physical activity behaviours may have a positive effect on 
sedentary lifestyles.  
 
Since the time my research was submitted for publication, one report of a similar study 
design was published by Kozey Keadle et al11 who found that combining exercise 
training with reductions in sedentary behaviour did not result in greater improvements in 
cardiometabolic health markers as compared to exercise alone. Their study was a 
controlled exercise trial where participants in exercise groups (either alone, or in 
conjunction with sedentary behaviour reductions) engaged in supervised exercise 
sessions for 200 minutes per week. Participants in sedentary behaviour groups (alone or 
combined with exercise) engaged in weekly face-to-face counselling sessions with 
research assistants to review daily activity profiles, set goals, and plan to overcome 
barriers. Despite the high intensity of the intervention (i.e. supervised exercise and 
weekly counselling), no differences were found between groups for metabolic 
outcomes.11 Their results corroborate the clinical findings from my research, presented in 
chapter two. 
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Shifting behaviours from sedentary to relatively higher-intensity physical activities like 
light activity or MVPA has important health implications. For example, each 30-minute 
bout of sedentary time reallocated to another intensity of physical activity (e.g. light, 
MVPA) improves cardiometabolic biomarkers such as waist circumference, high density 
lipoprotein cholesterol, triglycerides and insulin.12 This suggests that changes to daily 
activity behaviours, from sedentary to any higher intensity, can result in clinically 
meaningful changes to health outcomes. Results from systematic reviews of physical 
activity interventions suggest that individuals who change sedentary behaviours are likely 
to reallocate this time to higher-intensity physical activities, specifically MVPA.10,13 The 
demonstrated health effects of interrupting sedentary time underscore the potential 
importance of promoting reductions in sedentary time as a public health message in the 
years to come.  
 
5.2 Physical Activity Prescription 
A systematic review and meta-analysis of physical activity promotion interventions 
through primary care concluded that initiatives can significantly improve self-reported 
physical activity levels, and have a positive impact on cardiorespiratory fitness.14 The 
authors identified one study, which employed the STEP™ tool, as driving the effect on 
cardiorespiratory fitness. STEP™ is a clinical tool that includes a brief self-paced sub-
maximal stepping protocol followed by exercise prescription tailored to predicted aerobic 
fitness. The tool has been validated for clinical use among adults 18-85 years15,16 as well 
as for self-administration.17 Previously, we completed a review of published exercise 
interventions utilizing the STEP™ tool, which concluded that interventions employing 
STEP™ have demonstrated beneficial effects on aerobic fitness, exercise compliance, 
exercise self-efficacy, and risk factors associated with cardiovascular disease.18 
Therefore, based on existing evidence, STEP™ is an effective clinical tool to assess 
aerobic fitness and provide individualized exercise prescription.18 
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Results from the present research further demonstrate the clinical utility of the STEP™ 
tool for measuring and prescribing physical activity. Anecdotal reports from participants 
indicate that the prospect of undergoing the stepping test portion of STEP™ at the post-
intervention (12-week) visit was a driving force to initiate behaviour change. The effort 
of exertion required for the stepping test plus the knowledge of results was, in some 
cases, an impetus for change. For example, participants reported engaging in specific 
exercise behaviours (e.g. brisk walking, stair climbing at work and home) and nutrition 
behaviours (e.g. initiating a diet) to prepare for the subsequent stepping test in clinic. 
While the present research was not designed to control for this effect, it does support the 
treatment value of measuring fitness in clinic. As one participant identified at follow-up, 
“…I guess it’s that old adage in business: what doesn’t get measured doesn’t get done…” 
(61 year-old male, reported in chapter three). Results from previous literature combined 
with the current research demonstrate the importance of measuring health risk markers 
and suggest that this act of measurement may be a catalyst for change. 
 
5.3 mHealth 
A combination of rapid technological development paired with public demand for 
increased value in health services underscore the importance of developing and adopting 
personalized approaches in medicine and health care delivery.19 It has been suggested 
that health technologies and patients’ drive to use them will continue to transform health 
care practices.19 Therefore research employing tools like mHealth may continue to 
develop and demonstrate clinical utility. 
 
Recently, Bond et al20 reported an mHealth and sedentary behaviour intervention aimed 
at breaking up prolonged bouts of sedentary time among a sample of obese adults. They 
utilized an app to prompt breaks for three, six, or 12 minutes in duration related to length 
of sedentary time (30, 60, or 120 minute bouts, respectively). Results demonstrated 
significant reductions in sedentary time using the mHealth prompt.20 Additionally, 
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participants engaged in more light activity and MVPA during the breaks. Bond et al 
concluded that mHealth prompts can be used to initiate short, frequent breaks in 
prolonged sedentary behaviours.20 Results are promising as they demonstrate the 
potential value of mHealth for prompting change in physical activity behaviours.  
 
The mHealth research design for the present projects was informed by pilot work from 
Stuckey et al,21,22 which tested the mHealth protocols among a sample of rural adults with 
metabolic syndrome. These protocols were utilized in the same population for a 12-
month intervention focused on reducing blood pressure using mHealth paired with 
exercise prescription, which resulted in significant reductions in systolic blood pressure, 
but no difference between participants who used the mHealth kit versus those who logged 
measures using a paper journal.23 Results from that intervention suggest that it may be the 
process of ongoing measurement of personal health markers, and not the tool (i.e. paper 
log, mHealth) that may be the most important factor in managing health and preventing 
disease. Similarly, mHealth results from my research (presented in chapter three) 
demonstrate that among a sample of older adults motivated to volunteer for an mHealth 
study, the tools were equally effective among all groups. Moreover, qualitative results 
(presented in chapter four) highlight the participant views of selecting devices and 
approaches unique to individual needs and circumstances to promote adoption of 
prescribed behaviours. Personalized and tailored approaches to intervention may be ideal 
in designing optimal treatment therapies for patients. 
 
5.4 Limitations 
Quantitative results from the present research should be interpreted with caution due to 
the small sample size. Kozey Keadle et al11 recently reported a similar intervention 
design as reported here in chapters two and three, and employed the same sample size 
(n=60, 15 per group). Results from both reports may be used to inform the design of 
future interventions.  
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Although designed as a clinical aid, our research group has used the STEP™ tool widely 
in similar research. For the present projects we used predicted aerobic capacity measured 
through STEP™ as an outcome measure. Recently it was suggested that the tool is best 
used for clinical application to guide health professionals in tailored exercise 
prescription.15 Moreover, it was identified that STEP™ systematically over-predicts 
aerobic capacity as compared to a traditional laboratory-based VO2max testing protocol, 
which suggests that it may not be a strong outcome measure to use. However, the tool has 
been shown to be sensitive to change,16 and was used in the present projects to assess 
change over time through the clinical intervention.  
 
The present research provided pedometers to participants to encourage self-monitoring of 
physical activity behaviours. More sophisticated devices exist for measuring physical 
activity behaviours (e.g. accelerometers, inclinometers) and may be considered for use in 
future research. However, participants in the present research overwhelmingly reported 
their enjoyment of using the pedometers to self-monitor daily physical activity (chapter 
four). These qualitative results support the clinical value of using pedometers for 
participant satisfaction and adherence.  
 
Participants from the present research may have been highly motivated, as there was a 
very high retention rate (98% (n=59/60) completed the 12 week intervention). Therefore 
results may be limited in their application to future research among a broader, perhaps 
less motivated, clinical population. Analyses are warranted to describe characteristics of 
participants who responded well to the present intervention to identify individuals who 
may respond to future physical activity and mHealth interventions. These insights could 
enhance personalized approaches to intervention, whereby groups of populations with a 
greater likelihood of responding to a particular treatment approach could be identified.19 
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This knowledge would allow for tailoring of therapeutic interventions to participant 
needs and characteristics.  
 
5.5 Clinical Implications 
“Health care today is in a crisis as it is expensive, reactive, inefficient, and focused 
largely on one-size-fits-all treatments. An answer is personalized, predictive, preventive, 
and participatory medicine.”24 It has been suggested that personalized medicine can: 
contribute to the shift from reactive health services to preventive services (e.g. early 
intervention through lifestyle changes and disease-monitoring options to reduce risk of 
adverse health outcomes); help select optimal therapies (e.g. using risk markers to assist 
clinical decision making and reduce trial-and-error prescribing of behaviours); increase 
patient adherence to treatment (e.g. personalized therapies which are more effective may 
enhance engagement); improve quality of life through fewer adverse events; and reduce 
health care costs through increased efficiency.19 The quantitative and qualitative results 
from the present research suggest that personalized, tailored approaches to interventions 
may be a valuable focus for clinicians.  
 
Personalized medicine can be considered as delivering the ideal intervention for the 
patient at the optimal point in time to enhance their personal health outcomes. 
Traditionally, the phrase ‘personalized medicine’ tends to focus on tailoring health 
services and interventions based on genetic variables, and to-date the literature has 
focused on insights and advancements gained through gene mapping. The common 
thread among reports is that personalized medicine is relevant in selecting the ideal 
treatment for patients. In this sense, the term can also be applied to healthy living 
interventions, such as physical activity promotion and mHealth tools: selecting the right 
application for the right patient at the right time to create the best outcome. The research 
reported in chapters two through four highlight this effect: tailoring the physical activity 
targets to the individual’s abilities and desires, whether it be sedentary behaviour, 
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exercise behaviours or both; and selecting the tools to best enhance the individual’s 
understanding of their health and ongoing self-management, such as pedometers, 
smartphone apps, and devices to measure clinical markers (e.g. blood pressure or blood 
glucose monitors).  
 
Providing personalized care includes addressing patient needs, outcomes and preferences, 
and facilitating informed decision making for both clinicians and patients around 
comparative interventions.25 Personalized health care has the capacity to increase the 
efficiency of the health care system by improving quality, accessibility and 
affordability.19 Personalized approaches may offer even more substantial effects for 
managing chronic and complex conditions,19 therefore they may prove to be clinically 
meaningful for older adults living with multiple chronic conditions. It has been suggested 
that the benefit of personalized care is knowing what interventions are successful, 
understanding why, and applying that knowledge to address patient needs.19 It could also 
be argued that this is the basis of clinical decision-making. To assist clinicians in 
selecting optimal interventions, more research is needed to identify patients most likely to 
respond favourably to interventions such as physical activity prescription or mHealth for 
ongoing self-management. 
 
5.6 Research Directions 
Building on results from the current research, we identified an opportunity to take the 
exercise testing and prescription protocol (i.e. STEP™) out of the clinical setting and into 
the community. Preliminary work exploring the safety of administering STEP™ in a 
community location demonstrated safety and highlighted potential for self-
administration.26 Bridging this evidence with previous studies validating STEP™ for 
non-clinical use (i.e. home use)17 we have been working to develop a health application 
(app) which incorporates self-administration of STEP™. These initiatives enrich the 
ability to scale cardiorespiratory fitness measurement and personalized physical activity 
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prescription from clinical application to self-use, which could be leveraged for 
personalized medicine. Moving forward, clinicians may wish to introduce patients to 
tools like STEP™ for ongoing self-management and education.  
 
Research is warranted to identify personal variables that distinguish between responders 
and non-responders to intervention. For example, including analysis by demographic and 
clinical variables that distinguish highly responsive participants from minimally 
responsive participants. This information may help clinicians identify patients who are 
most likely to benefit from therapeutic intervention.  
 
Personalized approaches to medicine and health care pose challenges for research 
interventions. Specifically, when patients choose the intervention they are exposed to, 
how do we determine the effect of the intervention? Perhaps for behavioural 
interventions, patient choice may be the key variable of interest: can informed selection 
of intervention exposure lead to clinically meaningful outcomes? For the present 
research, this participant-centered variable was observed -anecdotally- among the control 
group. Participants were motivated to volunteer for a physical activity intervention, and 
even without receiving additional intervention were determined to make changes to 
perform better post-intervention (chapter two). 
 
5.7 Conclusion 
Healthy physical activity behaviours, which include regular bouts of MVPA and frequent 
interruptions in sedentary time, are integral to lifestyle-related disease prevention and 
management. Clinicians can prescribe changes to physical activity, and there is growing 
interest in targeting prescribed reductions for sedentary behaviours. Among a sample of 
community-dwelling older men and women, the present research demonstrated the 
importance of measuring markers for lifestyle related disease risk in clinic (chapter two) 
   
134 
as well as the utility of mHealth for managing markers of disease risk (chapter three). 
Participants identified the value of mHealth for patient education and creating social 
connections (chapter four). Additionally, clinical physical activity prescription 
underscored the role for and patient understanding of physical activity for managing 
health (chapter four).  Results of the physical activity prescription intervention were 
maintained long-term without additional intervention (chapter four), which demonstrates 
scalability of this approach. To enhance scalability, we have since explored options for 
community-based physical activity prescription26 as well as options for self-
administration of exercise testing and personalized physical activity prescription.17 Future 
research will need to explore the role of participant choice in selecting therapeutic 
intervention to enhance the effect of personalized medicine.  
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Appendix B Letter of Information for Intervention 
 
ARTEMIS-STEP™ Study 
Letter of Information 
Investigators: Robert J Petrella, MD, PhD; Melanie Stuckey, PhD (candidate); Emily 
Knight, MPT/PhD (student) 
Introduction 
You have expressed interest in participating in a research study investigating the impact 
of lifestyle changes on clinical and health measures like blood pressure, blood glucose, 
physical fitness, physical activity and wellbeing. You have spoken with research 
personnel over the phone to discuss the nature of this study, your potential eligibility to 
participate, and to schedule this first (of two) study visits. You are being invited to 
participate in this study. It is important that you read this description of the study and 
your role in it to help you decide if you would like to volunteer to participate. 
Who can participate? 
• In order to be eligible to participate, you must be between 55 and 75 years of age.  
• Your body mass index must be 27.0 kg/m2 or higher. Body mass index is a 
calculation of your height-to-weight ratio, and is determined by your family 
doctor. (We do not require that you know your body mass index.) 
• You must be willing to participate in this study for 12 consecutive weeks. 
• You must have read this letter of information about the nature and risks of 
participating. 
Your decision to participate is completely voluntary. If you chose to participate, you will 
provide your consent on the final page of this letter of information. 
Participant Initials: ______ 






Letter of Information 
 
Investigators: Robert J Petrella, MD, PhD; Melanie Stuckey, PhD (candidate); 
Emily Knight, MPT/PhD (student) 
 
Introduction 
You have expressed interest in participating in a research study investigating the 
impact of lifestyle changes on clinical and health measures like blood pressure, 
blood glucose, physical fitness, physical activity and wellbeing. You have spoken 
with research personnel over the phone to discuss the nature of this study, your 
potential eligibility to participate, and to schedule this first (of two) study visits. 
You are being invited to participate in this study. It is important that you read this 
descriptio  of the study and your role in it to help you decide if you would like to 
volunteer to participate. 
 
Who can participate? 
• In order to be eligible to participate, you must be between 55 and 75 years 
of age.  
• Your body ass index must be 27.0 kg/m2 or higher. Body mass index is a 
calculation f your height-to-weight ra io, and is determined by your family 
doctor. (We do not require that you know your body mass index.) 
• You must be willing to participate in this study for 12 consecutive weeks. 
• You must have read this letter of information about the nature and risks of 
participating. 
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Purpose of the Study 
An increasingly sedentary and obese Canadian population has caused an epidemic of 
lifestyle-related chronic conditions and diseases like high blood pressure and Type 2 
diabetes. Changes in blood pressure and blood glucose results in physiological changes in 
the cardiovascular system that can be identified very early in the laboratory (for example, 
through a simple blood test) and can be used to signal improvement with effective 
treatments to manage lifestyle-related conditions and diseases. Recent studies have 
shown that lifestyle interventions targeting physical activity are effective in lowering 
high blood pressure, improving physiological cardiovascular functioning and reducing 
cardiac disease.  
 
This study will look at the use of remote monitoring technologies (like smartphones and 
Bluetooth-enabled devices) as well as telephone counseling support to deliver a healthy 
living intervention for patients at-risk for developing lifestyle-related diseases and 
conditions.  
 
Length and Size of the Study 
This study involves 100 people from London and surrounding areas in southwestern 
Ontario. Each person will participate for 12 weeks. 
 
Study Tests and Procedures 
Screening – You have been asked a few questions over the phone to determine your 
eligibility to participate, and to ensure that participating in a healthy living intervention is 
safe and appropriate for you. During that phone call, you were scheduled to attend your 
two study visits, which is why you are here today.  
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Study Visits – If you chose to participate in this study, you will be asked to complete two 
visits (one today, and one 12 weeks from today) in London, Ontario. Each study visit will 
include a questionnaire that asks you about your physical activity and wellbeing, a 
stepping fitness test, and a blood draw. It is anticipated that these visits will last 
approximately 45-90 minutes. 
 
The stepping test consists of stepping up and down on a standardized set of steps 20 times 
at a pace that is comfortable for you. This is a predictive test of your maximum exercise 
ability, which will allow us to provide you with an estimate of how efficiently your heart 
and lungs can circulate oxygen (known as aerobic capacity or “VO2max”). If you 
consent, you will get to take home a record of this measure as well for your own 
information.  
 
For the blood draw, 20-30 cc (about 2-3 tablespoons) of blood will be drawn which will 
be used to measure your cholesterol, blood glucose and markers of your metabolism. You 
will be asked to fast for 8 hours prior to this test, but can drink water during these 8 
hours. Results from this test will also be sent to your family doctor. 
 
Before you begin your first visit as part of this study, you will be randomly selected (like 
the flip of a coin) to be in one of four study groups. This means that you will be assigned 
to participate in one of the four groups based on what side of the coin you are on. For this 
study, there is one Control Group and three Intervention Groups. What is involved to 
participate for each group is explained below. If you are assigned to the Intervention 
Groups you will be expected to participate in an activity program designed for you by an 
exercise specialist (CSEP-CEP®) on most days of the week for the entire 12-weeks of 
this study. Your personal activity program may include aerobic activities (for example, 
walking, riding a bike, running, swimming), resistance training activities (for example, 
lifting weights, push-ups, sit-ups, squats) and being more active during your daily routine 
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(for example, using stairs, walking to the store, standing while watching television or 
listening to music). The activity program designed for you will depend on your fitness 
level and activity preferences. 
1. Control Group –You will be required to attend two visits (today is the first visit). 
At each visit you will complete the stepping test as well as the blood draw, and will 
receive a copy of your estimated VO2max (from the stepping test), and a copy of the 
results from the blood draw will be sent to your family physician. For the 12-weeks 
between your two study visits you will be expected to carry on with your typical daily 
routine. This means we are not asking you to do anything extra during the 12 weeks 
between visits. However, should you become sick (i.e. seek out medical care or require 
hospitalization) we would ask that you inform the study team at your convenience so that 
we can consider if it is safe for you to continue with the study and complete your second 
clinic visit. 
2. Intervention Groups –You will be required to attend two visits (today is the first 
visit). At each visit you will complete the stepping test as well as the blood draw, and will 
receive a copy of your estimated VO2max (from the stepping test), and a copy of the 
results from the blood draw will be sent to your family physician. During this first visit 
you will receive an activity prescription from an exercise specialist (Canadian Society for 
Exercise Physiology Certified Exercise Physiologist®), which you will be encouraged to 
participate in during the study period (12 weeks). You will be required to submit regular 
measures that you can take from home and submit wirelessly using a Blackberry® 
smartphone.  The measures include: 
• Taking a blood sugar reading from a finger-prick glucometer device one time per 
week. 
• Measuring your blood pressure at home using a home blood pressure monitoring 
device three times per week. 
• Wearing a pedometer to measure the number of steps you take per day. 
We will provide you with all the technology (the smartphone and other wireless devices) 
that are part of this study as well as show you how to use them. You are expected to 
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return these study materials when you are finished participating in this study. Throughout 
the study, you will also have access to a specialist to ask questions about your devices at 
anytime. At the end of the 12 weeks, you will return to your family health team’s office 
for your second (final) clinic visit. 
Ongoing Contact for Intervention Groups – Throughout the study, participants in the 
Intervention Groups may be contacted over the phone –during appointments scheduled at 
your convenience- by someone involved with the research study (for example, your 
personal exercise specialist or a research assistant) to check in on your physical activity 
program and other measures, and to provide you with general support for any questions 
or concerns you may have. Should any of the readings you submit wirelessly be 
abnormal, the readings will be screened by a healthcare professional and you may be 
contacted should it be deemed necessary for your health. You will also have the freedom 
to speak with your personal exercise specialist at any point during the 12 weeks.  
 
Risks of Participating 
When blood samples are taken, you may feel some discomfort, develop some bruising, or 
in very rare cases develop a minor infection. Standardized sterilized techniques will be 
used by a trained specialist to minimize any risk.  You may also feel faint or nauseous.  
The specialist performing the blood draw is trained to deal with such situations.  
 
The clinic and home blood pressure monitoring cuffs used to measure blood pressure 
may cause some mild discomfort, bruising or red blood spots on the arm where the cuff is 
applied. There is a risk of pain when pricking your finger for the home blood glucose 
monitoring. Also, there is risk of infection during home blood glucose monitoring if 
proper hygiene and cleanliness are not followed. However, at your first clinic visit you 
will receive hands-on training from study personnel as well as written instructions for 
your reference about proper use of the equipment. You will also be able to contact study 
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personnel throughout the duration of the study if you have questions or concerns about 
the proper use of any of the equipment provided to you for your participation. 
 
The stepping test requires mild to moderate exertion by you, which may be 
uncomfortable. As a result, you may feel some of the symptoms of exercise (see below). 
If you develop any chest pain during the stepping test you must report this immediately to 
the study personnel.  
 
There is no known health risk associated with you becoming physically active under the 
supervision of a trained health professional. Exercise is associated with increased 
awareness of breathing, muscle pain, sweating and fatigue. These symptoms should 
resolve on stopping exercise and become less noticeable as your fitness improves. There 
is a small risk of injury with any form of exercise, however choosing activities that are 
familiar such as walking minimizes these risks. 
 
Benefits of Participating 
Participation in this study may be of no direct benefit to you. Positive changes in physical 
activity are an accepted strategy for controlling high blood glucose and treating high 
blood pressure: Increasing physical activity helps to manage lifestyle-related chronic 
conditions and diseases. Through participating in this study you may benefit from 
possible improvement in your glucose levels and blood pressure profile. Also, improved 
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Compensation and Costs 
You will not be paid to take part in this study. You will not be required to pay for any of 
the services associated with participating in this study. All study materials will be 
provided to you at no cost during the study period.  
 
Alternatives to Participating 
This study is completely voluntary, and you are not required to participate. Your 
healthcare from your family health team will not be affected by your participation in this 
study. If you choose to participate, you are free to withdraw from the study at any time 
and you will not be required to submit any future information to the study personnel. 
(Any data provided during the course of your participation will be retained.) If you 
withdraw you will be required to return the technology kit that had been loaned to you for 
the duration of your participation in this study.  
Voluntary Participation– Participation in this study is voluntary. You may refuse to 
participate, refuse to answer any questions or withdraw from the study at anytime with no 
effect on your future care. 
 
Contact Persons 
If during the course of this study you have any questions or concerns about this research 
study you may contact: 
1. Dr Robert Petrella at 519-685-4292, ext. 42075 
2. Melanie Stuckey at 519-685-4292, ext. 42856 
3. Emily Knight at 519-685-4292, ext. 42858 
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If you have any questions about the conduct of this study or your rights as a research 
participant or the conduct of the study you may contact: 
 The Office of Research Ethics at 519-661-3036 or ethics@uwo.ca 




The information you provide by participating in this study will be stored in a secure 
laboratory at Parkwood Hospital. At no time will you be identified by name during the 
course of data analysis or publication, as all participant data is number coded. The 
number code master list will be kept by Dr Robert Petrella in his secure office within the 
laboratory at the Aging, Rehabilitation and Geriatric Care Research Centre at Parkwood 
Hospital. 
 
Representatives of the University of Western Ontario Health Sciences Research Ethics 
Board may contact you or require access to your study-related records to monitor the 
conduct of the research. You do not waive any legal rights by consenting to participate in 
this study.  
 
 
You are encouraged to keep a copy of this information letter for your records.  
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ARTEMIS-STEP™ Study 
Informed Consent to Participate 
 
I ____________________________ have read the letter of information, have had the  
  (your name) 
nature of the study explained to me, and I agree to participate. And all questions have 
been answered to my satisfaction.  
__________________________     _______________ 
 Participant Signature       Date 
 
_________________________  _______  ________________ 
Name of Person Conducting   Initials    Date 
Consent 
 
! I would like results from this study shared with my family physician. 
Family physician contact information: 
 Name:     __________________________________________ 
 Clinic Location: __________________________________________ 
    __________________________________________ 
 Phone Number:  __________________________________________ 
 Fax Number:    __________________________________________ 
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Appendix C Letter of Information for Follow-Up 
 
ARTEMIS-STEP™ Study: Follow-Up 
Letter of Information 
Investigators: Robert J Petrella, MD, PhD; Melanie Stuckey, PhD (candidate); Emily 
Knight, MPT/PhD (student) 
 
Introduction 
Six months ago you completed the ARTEMIS-STEP™ study with us. We spoke with you 
over the phone or email, and booked this appointment for you to come in today to 
complete a follow-up visit. You are being invited to participate in this part of the study. It 
is important that you read this description of the part of the study and your role in it to 
help you decide if you would like to volunteer to participate. 
Who can participate? 
• In order to be eligible to participate, you must have completed the 12-weeks of 
the ARTEMIS-STEP™ Study. 
• You must have read this letter of information about the nature and risks of 
participating. 
Your decision to participate is completely voluntary. If you choose to participate, you 
will provide your consent on the final page of this letter of information. 
 
Participant Initials: ______ 






Letter of Information 
 
Investigators: Robert J Petrella, MD, PhD; Melanie Stuckey, PhD (candidate); 
Emily Knight, MPT/PhD (student) 
 
Introduction 
You have expressed interest in participating in a research study investigating the 
i pact of lifestyle changes on clinical and health measures like blood pressure, 
blood glucose, physical fitness, physical activity and wellbeing. You have spoken 
with research personnel over the phone to discuss the nature of this study, your 
potential eligibility to participate, and to schedule this first (of two) study visits. 
You are being invited to participate in this study. It is important that you read this 
description of the study and your role in it to help you decide if you would like to 
volunteer to participate. 
 
Who can participate? 
• In order to be eligible to participate, you must be between 55 and 75 years 
of age.  
• Your body mass index must be 27.0 kg/m2 or higher. Body mass index is a 
calculation of your height-to-weight ratio, and is determined by your family 
doctor. (We do not require that you know your body mass index.) 
• You must be willing to participate in this study for 12 consecutive weeks. 
• You must have read this letter of information about the nature and risks of 
participating. 
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Purpose of this Visit 
We are interested to know more about your experience participating in a healthy living 
intervention (that is, the ARTEMIS-STEP™ Study) as well has how your fitness has 
changed over the last 6 months since your most recent clinic visit with us. This part of the 
study will look at how fitness changes over time in people, just like you, who have 
recently participated in a healthy living intervention. It will also look into what it’s like to 
participate in a healthy living intervention. For example, what you learned through 
participating, and how you suggest designing future studies based on your experience.  
 
Length and Size of the Study 
This study involves the 100 people who participated in the ARTEMIS-STEP™ Study 6 
months ago. Each person who volunteers will participate in this phase one time for 
approximately 1 hour (that is, today’s visit).  
 
Procedures 
Participating in this visit involves completing the same stepping test that you did during 
the ARTEMIS-STEP™ Study, as well as answering up to 4 questions about your 
experience participating in this study. You are able to choose if you would like to 
complete both portions of this visit (that is the stepping test as well as the interview), or 
only 1 portion (either the stepping test or the interview). You will have an opportunity on 
the last page of this document to indicate which part(s) of this visit you would like to 
participate in.  
Stepping Test - The stepping test consists of stepping up and down on a standardized set 
of steps 20 times at a pace that is comfortable for you. This is a predictive test of your 
maximum exercise ability, which will allow us to provide you with an estimate of how 
efficiently your heart and lungs can circulate oxygen (known as aerobic capacity or 
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“VO2max”). If you consent, you will get to take home a record of this measure as well for 
your own information. Like the previous 2 study visits you completed, prior to 
completing this stepping test we will need to measure your height, weight and blood 
pressure. This portion of the visit should last less than 10 minutes. 
Interview – The interview involves up to 4 questions designed to help us better 
understand your experience participating in the ARTEMIS-STEP™ Study. These 
questions include topics like what you learned through participating that you use still use 
in your daily life 6 months later, and your opinions about using technology to help with 
physical activity. It is anticipated that this portion of the visit will last less than 20 
minutes. This interview will be audio recorded to help us ensure that we have captured 
the information you share accurately. During this interview, no personally identifying 
information will be asked (like your name, job, contact information, etc), and any 
personally identifying information you share will be removed from the audio recording 
after the interview.  
 
Risks of Participating 
The stepping test requires mild to moderate exertion by you, which may be 
uncomfortable. As a result, you may feel some of the symptoms of exercise (see below). 
If you develop any chest pain during the stepping test you must report this immediately to 
the study personnel.  
 
There is some risk that you may feel vulnerable discussing your experience in the study. 
Please remember that answering questions about your experience in the study is 
completely voluntary. If you do not feel comfortable answering these questions, you are 
free to stop at any time and will not be required to provide a reason for doing so. 
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Benefits of Participating 
Participation in this study may be of no direct benefit to you.  
 
Compensation and Costs 
You will not be paid to take part in this study. You will not be required to pay for any of 
the services associated with participating in this study. You will be provided with 
complimentary parking during your study visit today at Parkwood Hospital.  
 
Alternatives to Participating 
This study is completely voluntary, and you are not required to participate. If you choose 
to participate, you are free to withdraw from the study at any time and you will not be 
required to submit any future information to the study personnel. (Any data provided 
during the course of your participation will be retained.) 
Voluntary Participation– Participation in this study is voluntary. You may refuse to 
participate, refuse to answer any questions or withdraw from the study at anytime with no 
effect on your future health care. 
 
Contact Persons 
If during the course of this study you have any questions or concerns about this research 
study you may contact: 
4. Dr Robert Petrella at 519-685-4292, ext. 42075 
5. Melanie Stuckey at 519-685-4292, ext. 42856 
6. Emily Knight at 519-685-4292, ext. 42858 
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If you have any questions about the conduct of this study or your rights as a research 
participant or the conduct of the study you may contact: 
 Dr. David Hill, Scientific Director, Lawson Health Research Institute at  
 (519) 667-6649. 
 
Confidentiality 
During this visit, we will audio record the interview portion of this visit. This audio 
recording is not intended to include personal identifying information (like your name, 
job, address, etc). Any personally identifying information like this that you may share 
will be removed from the audio recording after the interview is finished. The information 
you provide by participating in this study will be stored in a secure laboratory at 
Parkwood Hospital. At no time will you be identified by name during the course of data 
analysis or publication, as all participant data is number coded. The number code master 
list will be kept by Dr Robert Petrella in his secure office within the laboratory at the 
Aging, Rehabilitation and Geriatric Care Research Centre at Parkwood Hospital. 
Representatives of the University of Western Ontario Health Sciences Research Ethics 
Board may contact you or require access to your study-related records to monitor the 
conduct of the research. You do not waive any legal rights by signing the consent form. 
 
You are encouraged to keep a copy of this information letter for your records. 
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ARTEMIS-STEP™ Study: Follow-Up 
Informed Consent to Participate 
 
I  ____________________________________ have read the letter of information, have 
  (your name) 
had the nature of the study explained to me, and I agree to participate. And all questions 
have been answered to my satisfaction.  
! I consent to completing the stepping test portion of this visit.  
! I consent to participating in the interview portion of this visit, and understand 
that that the answers I provide during the interview portion of this visit will be 
audio recorded. 
! I do not consent to participating in the interview portion of this visit  
 
____________________________    _______________ 
Participant Signature      Date 
 
______________________________   
Name of Person Conducting Consent 
 
______________________________   ________________ 
Signature of Person Conducting Consent   Date 
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